<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">756415</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2021.756415</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Intersegment Contacts of Potentially Damaging Variants of Cardiac Sodium Channel</article-title>
<alt-title alt-title-type="left-running-head">Korkosh et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">Nav1.5 Channelopathies</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Korkosh</surname>
<given-names>Vyacheslav S.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/570187/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zaytseva</surname>
<given-names>Anastasia K.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1279617/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kostareva</surname>
<given-names>Anna A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/495547/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhorov</surname>
<given-names>Boris S.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/234584/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<label>
<sup>1</sup>
</label>Almazov National Medical Research Centre, <addr-line>St. Petersburg</addr-line>, <country>Russia</country>
</aff>
<aff id="aff2">
<label>
<sup>2</sup>
</label>Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, <addr-line>St. Petersburg</addr-line>, <country>Russia</country>
</aff>
<aff id="aff3">
<label>
<sup>3</sup>
</label>Department of Women&#x2bc;s and Children&#x2bc;s Health, Karolinska Institute, <addr-line>Solna</addr-line>, <country>Sweden</country>
</aff>
<aff id="aff4">
<label>
<sup>4</sup>
</label>Department of Biochemistry and Biomedical Sciences, McMaster University, <addr-line>Hamilton</addr-line>, <addr-line>ON</addr-line>, <country>Canada</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1158914/overview">Heather Ray</ext-link>, Idaho State University, United&#x20;States</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/709290/overview">Hannes Todt</ext-link>, Medical University of Vienna, Austria</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/55743/overview">Matthew Perry</ext-link>, Victor Chang Cardiac Research Institute, Australia</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Boris S. Zhorov, <email>zhorov@mcmaster.ca</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Pharmacology of Ion Channels and Channelopathies, a section of the journal Frontiers in Pharmacology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>04</day>
<month>11</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>12</volume>
<elocation-id>756415</elocation-id>
<history>
<date date-type="received">
<day>10</day>
<month>08</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>10</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2021 Korkosh, Zaytseva, Kostareva and Zhorov.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Korkosh, Zaytseva, Kostareva and Zhorov</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<abstract>
<p>Over 1,500 missense variants of sodium channel hNav1.5, which are reported in the ClinVar database, are associated with cardiac diseases. For most of the variants, the clinical significance is uncertain (VUS), not provided (NP), or has conflicting interpretations of pathogenicity (CIP). Reclassifying these variants as pathogenic/likely pathogenic (P/LP) variants is important for diagnosing genotyped patients. In our earlier work, several bioinformatics tools and paralogue annotation method consensually predicted that 74 VUS/NP/CIP variants of 54 wild type residues (set w54) are potentially damaging variants (PDVs). Atomic mechanisms underlying dysfunction of the PDVs are unknown. Here we employed a recent cryo-EM structure of the hNav1.5 channel with likely inactivated pore domain (PD) and activated voltage-sensing domains (VSDs), and <italic>ad hoc</italic> models of the closed and open PD and resting VSDs to explore intersegment contacts of w54 residues. We found that 44 residues from set w54 contact 84 residues with 118 disease missense variants. These include 104 VUS/NP/CIP variants, most of which are associated with the loss-of-function Brugada syndrome (BrS1) or gain-of-function long QT syndrome (LQT3). Matrix representation of the PDVs and their contact variants facilitated recognition of coupled mutations associated with the same disease. In particular, BrS1-associated coupled mutations, which disturb the P-loops region with the selectivity filter slow inactivation gate, would cause the channel dysfunction. Other likely causes of the channel dysfunction include coupled BrS1-associated variants within VSDs that would destabilize their activated states and coupled LQT3-associated variants, which would stabilize the open PD or activated VSDs. Our study proposes mechanisms of channel dysfunction for scores of BrS1- and LQT3-associated variants, confirms status for 82% of PDVs, and suggests damaging status for their contact variants, which are currently categorized as VUS/NP/CIP variants.</p>
</abstract>
<kwd-group>
<kwd>Brugada syndrome</kwd>
<kwd>cardiac arrhythmias</kwd>
<kwd>cryo-EM structure</kwd>
<kwd>homology modeling</kwd>
<kwd>intersegment contacts</kwd>
<kwd>long QT syndrome</kwd>
<kwd>Monte Carlo minimizations</kwd>
</kwd-group>
<contract-sponsor id="cn001">Russian Foundation for Basic Research<named-content content-type="fundref-id">10.13039/501100002261</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">Natural Sciences and Engineering Research Council of Canada<named-content content-type="fundref-id">10.13039/501100000038</named-content>
</contract-sponsor>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Sodium channels Nav1.5 are responsible for initiation and propagation of the action potential in cardiomyocytes. The pore-forming &#x3b1;-subunit of the Nav1.5 channel, which is encoded by gene SCN5A, folds from a single polypeptide chain of four homologous repeat domains (I-IV). Each repeat has six transmembrane (TM) helices (S1-S6) connected by intra- and extracellular loops, including a large extracellular membrane reentering P-loop. The latter contains membrane-descending helix P1 and membrane-ascending helix P2. In each repeat, helices S1 - S4 form a voltage-sensing domain (VSD), while helices S5, S6 and the P-loop contribute a quarter to the pore domain (PD). The selectivity-filter ring DEKA (Asp, Glu, Lys and Ala) divides the ion permeation pathway into two parts: extracellularly exposed outer pore and the inner pore, which in the open channel is exposed to the cytoplasm. Sodium channels adopt various conformations, which in electrophysiological studies are categorized as resting, open, fast inactivated and slow inactivated states.</p>
<p>Sodium channels allow permeation of inward depolarizing current (I<sub>Na</sub>) during phase 0 of the action potential (<xref ref-type="bibr" rid="B1">Amin et&#x20;al., 2010</xref>; <xref ref-type="bibr" rid="B63">Veerman et&#x20;al., 2015</xref>). Nav1.5 dysfunctions cause various hereditary and acquired arrhythmogenic syndromes. Many genetic gain-of-function mutations increase I<sub>Na</sub> or delay cardiac repolarization, thus prolonging the action potential (<xref ref-type="bibr" rid="B45">Savio-Galimberti et&#x20;al., 2018</xref>). Such mutations are associated with the long QT syndrome (LQT3), a congenital cardiac disorder, which is characterized by prolonged QT interval and higher risk of life-threatening arrhythmia. Clinical manifestations of LQT3 vary from life-long asymptomatic disease course to syncope and cardiac arrest due to torsades de pointes. Mutations, which diminish I<sub>Na</sub>, may decrease cardiac excitability and reduce velocity of electrical conduction, causing various clinical phenotypes such as Brugada syndrome type 1 (BrS1), sick sinus syndrome, sudden infant death syndrome, dilated cardiomyopathy, atrial fibrillation, and arrhythmogenic cardiomyopathy. BrS1 is diagnosed <italic>via</italic> typical ECG-phenomenon with ST-segment elevation in ventricular leads without any structural alterations of the heart (<xref ref-type="bibr" rid="B11">Coppola et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B49">Skinner et&#x20;al., 2019</xref>).</p>
<p>Thousands genetic variants of hNav1.5 and other hNav1.x channels are described in public databases, including ClinVar (<xref ref-type="bibr" rid="B27">Landrum et&#x20;al., 2016</xref>), Swiss-Var (<xref ref-type="bibr" rid="B35">Mottaz et&#x20;al., 2010</xref>) and Humsavar (<ext-link ext-link-type="uri" xlink:href="http://www.uniprot.org/docs/humsavar">http://www.uniprot.org/docs/humsavar</ext-link>). In April 2021, the ClinVar database reported 1,513 missense variants of SCN5A. Among these, only 17% are classified as benign/likely benign or pathogenic/likely pathogenic (P/LP) variants according to the American College of Medical Genetics and Genomics and the Association for Molecular Pathology (ACMG/AMP) guideline (<xref ref-type="bibr" rid="B41">Richards et&#x20;al., 2015</xref>). Data on pathogenicity is not provided (NP) for 200 variants, conflicting interpretations of pathogenicity (CIP) are reported for 139 variants, and 911 variants are of uncertain clinical significance (VUS).</p>
<p>The ACMG/AMP guideline recommends using computational predictions as a line of evidence for variant interpretation (<xref ref-type="bibr" rid="B41">Richards et&#x20;al., 2015</xref>). Bioinformatics analysis of variants associated with BrS1 suggests that some mutations, which are currently classified as damaging, should be considered benign due to lack of experimental data on channel dysfunction (<xref ref-type="bibr" rid="B21">Kaltman et&#x20;al., 2018</xref>). Incorrect classification of variants is an important problem in medical genetics. Indeed, in many cases a familial history or the pedigree data are lacking. Low frequency of disease-associated genetic variants in population further complicates correct data interpretation and delays diagnostics.</p>
<p>Earlier we employed several bioinformatics tools and the paralogue annotation method to reclassify 74&#x20;ClinVar-reported VUS/NP/CIP variants of 54 WT residues (set w54) as potentially damaging variants (PDVs) of hNav1.5 (<xref ref-type="bibr" rid="B55">Tarnovskaya et&#x20;al., 2020</xref>). Here we used a recent cryo-EM structure of the hNav1.5 channel with likely inactivated PD and activated VSDs (<xref ref-type="bibr" rid="B30">Li et&#x20;al., 2021</xref>), and <italic>ad-hoc</italic> models of the open and closed PD and resting VSDs to show that 44 residues from set w54 are involved in 84 intersegment contacts with residues for which 118 missense variants are reported in ClinVar, mostly as VUS/NP/CIP variants. Matrix representation of the PDVs and their contact variants facilitated recognition of coupled variants where substitution of either contact partner is associated with the same disease. We suggest that BrS1-associated variants in P-loops and VSDs would cause loss of channel function, respectively, by disturbing the selectivity-filter slow inactivation gate or destabilizing activated state of VSDs. LQT3-associated variants would cause the channel gain-of-function by increasing population of channels with the open pore. Our analysis confirms the status for most of earlier proposed PDVs, suggests that many of the 118 contact variants of the PDVs may be reclassified as P/LP variants, and proposes atomic mechanisms of loss-of-functions and gain-of function for scores of BrS1-associated and LQT3-associated mutations.</p>
</sec>
<sec sec-type="methods" id="s2">
<title>Methods</title>
<sec id="s2-1">
<title>Energy Calculations and Optimization</title>
<p>Our methodology of molecular modeling with the ZMM program is described elsewhere, e.g., (<xref ref-type="bibr" rid="B6">Bruhova and Zhorov, 2010</xref>; <xref ref-type="bibr" rid="B26">Korkosh et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B59">Tikhonov and Zhorov, 2017</xref>). Briefly, we use the AMBER force field (<xref ref-type="bibr" rid="B65">Weiner et&#x20;al., 1986</xref>) and calculate nonbonded interactions with the distance cutoff of 9&#xa0;&#xc5; and a shifting function (<xref ref-type="bibr" rid="B5">Brooks et&#x20;al., 1985</xref>). Electrostatic interactions were calculated with the distance- and environment-dependent dielectric function (<xref ref-type="bibr" rid="B15">Garden and Zhorov, 2010</xref>) without the distance cutoff for interactions involving ionized groups. The models were optimized by Monte Carlo energy minimizations (MCM) (<xref ref-type="bibr" rid="B31">Li and Scheraga, 1987</xref>) in the space of torsional angles and bond angles of prolines (<xref ref-type="bibr" rid="B70">Zhorov, 1981</xref>). MCM trajectories were terminated when 2,000 minimizations did not decrease energy of the apparent global minimum.</p>
</sec>
<sec id="s2-2">
<title>Modeling PD in the Open and Closed States</title>
<p>The hNav1.5 structure with quinidine (PDB ID: 6lqa) captured PD in likely inactivated state and VSDs in the activated states (<xref ref-type="bibr" rid="B30">Li et&#x20;al., 2021</xref>). To model PD in the activated and closed states, we used as templates the open- and closed-pore structures of the NavAb channel (PDB codes 5vb8 and 5vb2, respectively) (<xref ref-type="bibr" rid="B28">Lenaeus et&#x20;al., 2017</xref>). The structures of Nav1.5 and NavAb were 3D aligned by minimizing root mean square deviations of C<sup>&#x3b1;</sup> atoms in the P1 helices, which are the most 3D-conserved elements of P-loop channels (<xref ref-type="bibr" rid="B58">Tikhonov and Zhorov, 2012</xref>), from C<sup>&#x3b1;</sup> atoms of sequentially matching residues in the Kv1.2/Kv2.1 channel, the first eukaryotic P-loop channel whose crystal structure was obtained at a relatively high resolution below 2.5&#xa0;&#xc5; (PDB ID: 2R9R) (<xref ref-type="bibr" rid="B33">Long et&#x20;al., 2007</xref>). The NavAb and hNav1.5 channels have rather similar folding of the transmembrane (TM) and P1 helices, but different folding of extracellular loops, especially in the PD. Therefore, we imposed distance constraints between C<sup>&#x3b1;</sup> atoms in the TM and P1 helices of hNav1.5 and matching C<sup>&#x3b1;</sup> atoms of the template, whereas no distance constraints were imposed to the intra- and extracellular loops. A distance constraint is a flat-bottom parabolic function that imposes the energy penalty with the force constraint of 10&#xa0;kcal&#xb7;mol<sup>&#x2212;1</sup>&#xa0;&#xc5;<sup>&#x2212;2</sup> if a C<sup>&#x3b1;</sup> atom in the model deviates from the template matching atom by more than 2&#xa0;&#xc5;. The 3D alignment was performed by step-wise reducing distances between the C<sup>&#x3b1;</sup> atoms in the model and template. At each step, the energy was MC-minimized with all degrees of freedom allowed to vary. More methodological details on large-scale transformations of PD can be found elsewhere (<xref ref-type="bibr" rid="B25">Korkosh et&#x20;al., 2019</xref>).</p>
</sec>
<sec id="s2-3">
<title>Modeling VSDs in the Resting States</title>
<p>To model VSDs in the resting states, we employed as a template the crystal structure of the prokaryotic sodium channel NavAb with deactivated VSDs (PDB ID: 6p6x) (<xref ref-type="bibr" rid="B66">Wisedchaisri et&#x20;al., 2019</xref>). Methodology is similar to that used for modeling the channel with the open and closed&#x20;PD.</p>
</sec>
<sec id="s2-4">
<title>Designations and Visualization of Residues</title>
<p>We designate a residue by one-letter code with superscripted residue number and superscripted prefix indicating the channel segment where the residue is located. Experimental structures and models were visualized with the PyMol Molecular Graphics System, version 0.99rc (Schr&#xf6;dinger, New York,&#x20;NY).</p>
</sec>
</sec>
<sec sec-type="results|discussion" id="s3">
<title>Results and Discussions</title>
<sec id="s3-1">
<title>Intersegment Contacts in the Cryo-EM Structure</title>
<p>Earlier, we employed several bioinformatics tools and paralogue annotation method to reclassify 74 missense VUS/NP/CIP variants of w54 residues in the hNav1.5 channel as PDVs (<xref ref-type="bibr" rid="B55">Tarnovskaya et&#x20;al., 2020</xref>). Following this publication, eight additional VUS/NP/CIP variants of the w54 residues were reported in ClinVar (version April, 2021). Therefore, currently the PDV set includes 82 variants.</p>
<p>We used a recent cryo-EM structure of the hNav1.5 channel obtained in nanodiscs (<xref ref-type="bibr" rid="B30">Li et&#x20;al., 2021</xref>) to find intersegment contacts of the w54 residues. We instructed PyMol to display 3D neighbor residues within 5&#xa0;&#xc5; from each query residue of set w54. Since the cryo-EM structure lacks hydrogen atoms, the distances were measured between heavy atoms. We have selected those 3D neighbors, which in the amino acid sequence are at least 5 positions away from the query residue and have sidechains facing the query residue sidechain (C<sup>&#x3b1;</sup> atoms of glycines were considered as sidechains). We further ensured that each 3D neighbor of the query residue has at least one ClinVar-reported missense variant. We found 64 contact residues, which satisfied the above criteria and 85 missense variants of these residues. If two WT residues form a contact, their variants are also considered to contact each other even though they may be farther than 5&#xa0;&#xc5; from each&#x20;other.</p>
<p>
<xref ref-type="table" rid="T1">Table&#x20;1</xref> shows PDVs and their contact variants in the PD. For each PDV we show location (channel segment), all contact variants, associated syndromes, and their clinical significance. <xref ref-type="table" rid="T2">Table&#x20;2</xref> shows analogous data for VSDs. Among 85 contact variants, 74 are VUS/NP/CIP variants and clinical significance of 11 variants is P/LP. Four pairs of residues from set w54 are contacting each other (columns &#x201c;e&#x201d; in <xref ref-type="table" rid="T1">Table&#x20;1</xref>). Contacts involving channel segments that undergo significant transition upon channel gating are marked &#x201c;S&#x201d; in column &#x201c;f&#x201d;.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>PDVs in the pore domain and their contacts<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th colspan="3" align="left">PDVs</th>
<th colspan="5" align="center">Contacts</th>
</tr>
<tr>
<th colspan="2" align="left">Variant<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
</th>
<th align="center">Syndrome<xref ref-type="table-fn" rid="Tfn3">
<sup>c</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn4">
<sup>d</sup>
</xref>
</th>
<th align="center">Variant</th>
<th align="center">Syndrome<xref ref-type="table-fn" rid="Tfn4">
<sup>d</sup>
</xref>
</th>
<th align="center">Significance</th>
<th align="center">
<xref ref-type="table-fn" rid="Tfn5">
<sup>e</sup>
</xref>
</th>
<th align="center">
<xref ref-type="table-fn" rid="Tfn6">
<sup>f</sup>
</xref>
</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td colspan="2" align="right">
<sup>IS5</sup>A<sup>242</sup>T</td>
<td align="left">A</td>
<td rowspan="2" align="right">
<sup>IS6</sup>Q<sup>419</sup>P</td>
<td rowspan="2" align="left">BrS1, NP</td>
<td rowspan="2" align="left">VUS</td>
<td rowspan="10" align="left"/>
<td rowspan="2" align="left">S</td>
</tr>
<tr>
<td colspan="2" align="right">V</td>
<td align="left">HCM</td>
</tr>
<tr>
<td colspan="2" align="right">
<sup>IS5</sup>L<sup>250</sup>V</td>
<td align="left">BrS1</td>
<td align="right">
<sup>IS6</sup>V<sup>411</sup>M</td>
<td align="left">LQT3, BrS1, CVP</td>
<td align="left">P</td>
<td rowspan="2" align="left">S</td>
</tr>
<tr>
<td colspan="2" align="right">
<sup>IS5</sup>S<sup>262</sup>G</td>
<td align="left">A, BrS1</td>
<td align="right">
<sup>IP1</sup>F<sup>358</sup>S</td>
<td align="left">NS</td>
<td align="left">VUS</td>
</tr>
<tr>
<td colspan="2" align="right">
<sup>IS5</sup>V<sup>263</sup>I</td>
<td align="left">Multi</td>
<td align="right">
<sup>IVS4</sup>I<sup>1633</sup>V</td>
<td align="left">BrS1</td>
<td align="left">VUS</td>
<td rowspan="3" align="left">S</td>
</tr>
<tr>
<td rowspan="2" colspan="2" align="right">
<sup>IS5-P1</sup>G<sup>274</sup>S</td>
<td rowspan="2" align="left">BrS1</td>
<td align="right">
<sup>IS5-P1</sup>D<sup>356</sup>Y</td>
<td align="left">BrS1</td>
<td align="left">LP</td>
</tr>
<tr>
<td align="right">N</td>
<td align="left">NP/BrS1</td>
<td align="left">P/LP</td>
</tr>
<tr>
<td colspan="2" align="right">
<sup>IS6</sup>A<sup>413</sup>E</td>
<td align="left">LQT3</td>
<td rowspan="3" align="right">
<sup>IIS6</sup>L<sup>935</sup>P</td>
<td rowspan="3" align="left">BrS1</td>
<td rowspan="3" align="left">NP</td>
<td rowspan="3" align="left">S</td>
</tr>
<tr>
<td colspan="2" align="right">S</td>
<td align="left">NS</td>
</tr>
<tr>
<td colspan="2" align="right">T</td>
<td align="left">A, LQT3,BrS1</td>
</tr>
<tr>
<td colspan="2" align="right">
<sup>IIS5</sup>G<sup>857</sup>D</td>
<td align="left">A, BrS1</td>
<td align="right">
<sup>IIS5-P1</sup>M<sup>881</sup>I</td>
<td align="left">LQT3</td>
<td align="left">VUS</td>
<td align="center">1</td>
<td align="left"/>
</tr>
<tr>
<td rowspan="2" colspan="2" align="right">
<sup>IIS5-P1</sup>M<sup>881</sup>I</td>
<td rowspan="2" align="left">LQT3</td>
<td align="right">
<sup>IIS6</sup>F<sup>919</sup>S</td>
<td align="left">NS</td>
<td align="left">LP</td>
<td rowspan="2" align="center">1</td>
<td rowspan="2" align="left"/>
</tr>
<tr>
<td align="right">
<sup>IIS5</sup>G<sup>857</sup>D</td>
<td align="left">A, BrS1</td>
<td align="left">VUS</td>
</tr>
<tr>
<td colspan="2" align="right">
<sup>IIP1</sup>F<sup>892</sup>L</td>
<td align="left">CVP</td>
<td align="right">
<sup>IVS6</sup>V<sup>1451</sup>D</td>
<td align="left">BrS1</td>
<td align="left">VUS</td>
<td rowspan="2" align="center">2</td>
<td rowspan="2" align="left"/>
</tr>
<tr>
<td colspan="2" align="right">I</td>
<td align="left">BrS1</td>
<td align="right">L</td>
<td align="left">NS, A</td>
<td align="left">VUS</td>
</tr>
<tr>
<td colspan="2" align="right">
<sup>IIP1</sup>R<sup>893</sup>H</td>
<td align="left">BrS1<sup>1,3,4,8&#x2013;10</sup>
</td>
<td rowspan="2" align="right">
<sup>IIP2</sup>E<sup>901</sup>K</td>
<td rowspan="2" align="left">BrS1</td>
<td rowspan="2" align="left">VUS</td>
<td rowspan="9" align="center">2</td>
<td rowspan="3" align="left">S</td>
</tr>
<tr>
<td colspan="2" align="right">C</td>
<td align="left">BrS1</td>
</tr>
<tr>
<td colspan="2" align="right">
<sup>IIIS5</sup>V<sup>1324</sup>I</td>
<td align="left">A, BrS1, NP</td>
<td align="right">
<sup>IIS3</sup>W<sup>1271</sup>C</td>
<td align="left">BrS1</td>
<td align="left">NP</td>
</tr>
<tr>
<td colspan="2" align="right">
<sup>IIIS5</sup>L<sup>1342</sup>F</td>
<td align="left">BrS1</td>
<td align="right">
<sup>IIIP1</sup>Y<sup>1409</sup>C</td>
<td align="left">BrS1</td>
<td align="left">NP</td>
<td rowspan="7" align="left">S</td>
</tr>
<tr>
<td colspan="2" align="right">
<sup>IIIP1</sup>L<sup>1410</sup>P</td>
<td align="left">NP</td>
<td align="right">
<sup>IIIS5-P2</sup>V<sup>1400</sup>G</td>
<td align="left">CVP</td>
<td align="left">VUS</td>
</tr>
<tr>
<td rowspan="2" colspan="2" align="right">
<sup>IIIP2</sup>I<sup>1424</sup>F</td>
<td rowspan="2" align="left">NP</td>
<td align="right">
<sup>IIIS5-P1</sup>F<sup>136</sup>&#xb0;C</td>
<td align="left">BrS1</td>
<td align="left">NP</td>
</tr>
<tr>
<td align="right">
<sup>IIIS5-P1</sup>V<sup>1400</sup>G</td>
<td align="left">CVP</td>
<td align="left">VUS</td>
</tr>
<tr>
<td colspan="2" align="right">
<sup>IIIS6</sup>V<sup>1451</sup>D</td>
<td align="left">BrS1<sup>1,3</sup>
</td>
<td align="right">
<sup>IIP1</sup>F<sup>892</sup>L</td>
<td align="left">CVP</td>
<td align="left">VUS</td>
</tr>
<tr>
<td colspan="2" align="left">L</td>
<td align="left">A, NS</td>
<td align="right">I</td>
<td align="left">BrS1</td>
<td align="left">NP</td>
</tr>
<tr>
<td colspan="2" align="right">
<sup>IIIS6</sup>N<sup>1463</sup>K</td>
<td align="left">NP</td>
<td align="right">
<sup>IIS6</sup>F<sup>934</sup>S</td>
<td align="left">BrS1</td>
<td align="left">VUS</td>
<td align="left"/>
</tr>
<tr>
<td rowspan="5" colspan="2" align="right">
<sup>IIIS6</sup>F<sup>1465</sup>L</td>
<td rowspan="5" align="left">LQT3</td>
<td align="right">
<sup>IIIS5</sup>V<sup>1337</sup>I</td>
<td align="left">A</td>
<td align="left">VUS</td>
<td rowspan="5" align="left"/>
<td align="left">S</td>
</tr>
<tr>
<td align="right">
<sup>IIIS5</sup>I<sup>1334</sup>V</td>
<td align="left">LQT3, BrS1, NP</td>
<td align="left">CIP</td>
<td align="left">S</td>
</tr>
<tr>
<td align="right">
<sup>IVS6</sup>F<sup>176</sup>&#xb0;C</td>
<td align="left">BrS1</td>
<td align="left">P</td>
<td align="left">S</td>
</tr>
<tr>
<td align="right">
<sup>IVS6</sup>L<sup>1761</sup>F</td>
<td align="left">LQT3</td>
<td align="left">NP</td>
<td rowspan="2" align="left">S</td>
</tr>
<tr>
<td align="right">H</td>
<td align="left">LQT3</td>
<td align="left">NP</td>
</tr>
<tr>
<td colspan="2" align="right">
<sup>IIIS6</sup>I<sup>1466</sup>T</td>
<td align="left">NP, A</td>
<td align="right">
<sup>IIS6</sup>F<sup>934</sup>S</td>
<td align="left">BrS1</td>
<td align="left">VUS</td>
<td rowspan="3" align="left"/>
<td align="left">S</td>
</tr>
<tr>
<td rowspan="2" colspan="2" align="right">V</td>
<td rowspan="2" align="left">NP</td>
<td align="right">
<sup>IVS6</sup>V<sup>1764</sup>F</td>
<td align="left">BrS1</td>
<td align="left">NP</td>
<td align="left">S</td>
</tr>
<tr>
<td align="right">
<sup>IVS6</sup>F<sup>176</sup>&#xb0;C</td>
<td align="left">BrS1</td>
<td align="left">P</td>
<td align="left">S</td>
</tr>
<tr>
<td rowspan="2" colspan="2" align="right">
<sup>IIIS6</sup>V<sup>1468</sup>A</td>
<td rowspan="2" align="left">A, BrS1,NP</td>
<td align="right">
<sup>IIIS5</sup>S<sup>1333</sup>Y</td>
<td align="left">LQT3</td>
<td align="left">NP</td>
<td rowspan="2" align="left"/>
<td align="left">S</td>
</tr>
<tr>
<td align="right">
<sup>IIIS5</sup>V<sup>1337</sup>I</td>
<td align="left">A</td>
<td align="left">VUS</td>
<td align="left">S</td>
</tr>
<tr>
<td rowspan="4" colspan="2" align="right">
<sup>IIIS6</sup>I<sup>1469</sup>F</td>
<td rowspan="4" align="left">NP</td>
<td align="right">
<sup>IIIS5</sup>I<sup>1334</sup>V</td>
<td align="left">LQT3, BrS1, NP</td>
<td align="left">CIP</td>
<td rowspan="4" align="left"/>
<td align="left">S</td>
</tr>
<tr>
<td align="right">
<sup>IVS6</sup>L<sup>1761</sup>F</td>
<td align="left">LQT3</td>
<td align="left">NP</td>
<td align="left">S</td>
</tr>
<tr>
<td align="right">H</td>
<td align="left">LQT3</td>
<td align="left">NP</td>
<td rowspan="2" align="left">S</td>
</tr>
<tr>
<td align="right">
<sup>IVS6</sup>V<sup>1764</sup>F</td>
<td align="left">BrS1</td>
<td align="left">NP</td>
</tr>
<tr>
<td colspan="2" align="right">
<sup>IVS5</sup>V<sup>1667</sup>L</td>
<td align="left">NP</td>
<td align="right">
<sup>IVS6</sup>I<sup>1758</sup>V</td>
<td align="left">A, BrS1</td>
<td align="left">VUS</td>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td colspan="2" align="right">
<sup>IVS5-P1</sup>D<sup>1690</sup>N</td>
<td align="left">A, BrS1, NS<sup>14,15,16</sup>
</td>
<td align="right">
<sup>IP2</sup>R<sup>383</sup>K</td>
<td align="left">BrS1</td>
<td align="left">VUS</td>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td rowspan="5" colspan="2" align="right">
<sup>IVP1</sup>M<sup>1701</sup>I</td>
<td rowspan="5" align="left">BrS1, DCM<sup>17</sup>
</td>
<td align="right">
<sup>IVS5</sup>M<sup>1668</sup>T</td>
<td align="left">A</td>
<td align="left">VUS</td>
<td rowspan="5" align="left"/>
<td rowspan="5" align="left"/>
</tr>
<tr>
<td align="right">
<sup>IS6</sup>M<sup>390</sup>I</td>
<td align="left">A</td>
<td align="left">VUS</td>
</tr>
<tr>
<td align="right">V</td>
<td align="left">BrS1, A</td>
<td align="left">VUS</td>
</tr>
<tr>
<td align="right">
<sup>IS6</sup>M<sup>394</sup>I</td>
<td align="left">A</td>
<td align="left">VUS</td>
</tr>
<tr>
<td align="right">L</td>
<td align="left">A</td>
<td align="left">VUS</td>
</tr>
<tr>
<td colspan="2" rowspan="11" align="right">
<sup>IVS5</sup>I<sup>1660</sup>V</td>
<td rowspan="11" align="left">NP, CVP, BrS1, LQT3<sup>1,3,13,14</sup>
</td>
<td align="right">
<sup>IVS6</sup>V<sup>1764</sup>F</td>
<td align="left">BrS1</td>
<td align="left">NP</td>
<td rowspan="11" align="char" char=".">3</td>
<td align="left">S</td>
</tr>
<tr>
<td align="right">
<sup>IVS6</sup>L<sup>1761</sup>F</td>
<td align="left">LQT3</td>
<td align="left">NP</td>
<td align="center">S</td>
</tr>
<tr>
<td align="right">H</td>
<td align="left">LQT3</td>
<td align="left">NP</td>
<td align="center">S</td>
</tr>
<tr>
<td align="right">
<sup>IIIS4-S5</sup>V<sup>1323</sup>G</td>
<td align="left">BrS1</td>
<td align="left">NP</td>
<td align="center">S</td>
</tr>
<tr>
<td align="right">I</td>
<td align="left">A, BrS1</td>
<td align="left">VUS</td>
<td align="center">S</td>
</tr>
<tr>
<td align="right">
<sup>IVS6</sup>M<sup>1766</sup>I</td>
<td align="left">CVP, BrS1</td>
<td align="left">VUS</td>
<td rowspan="6" align="center">S</td>
</tr>
<tr>
<td align="right">K</td>
<td align="left">NP, BrS1, SSS</td>
<td align="left">VUS</td>
</tr>
<tr>
<td align="right">V</td>
<td align="left">BrS1</td>
<td align="left">VUS</td>
</tr>
<tr>
<td align="right">T</td>
<td align="left">HCM</td>
<td align="left">VUS</td>
</tr>
<tr>
<td align="right">L</td>
<td align="left">LQT3</td>
<td align="left">P</td>
</tr>
<tr>
<td align="right">
<sup>IIIS6&#x2212;IVS1</sup>F<sup>1486</sup>L</td>
<td align="left">SIDS</td>
<td align="left">NP</td>
</tr>
<tr>
<td colspan="2" align="right">
<sup>IVP1</sup>L<sup>1704</sup>H</td>
<td align="left">BrS1</td>
<td align="right">
<sup>IVS5</sup>M<sup>1668</sup>T</td>
<td align="left">A</td>
<td align="left">VUS</td>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td rowspan="4" colspan="2" align="right">
<sup>IVP1</sup>T<sup>1709</sup>M</td>
<td rowspan="4" align="left">A, BrS1,CVP,NP<sup>1,3,18</sup>
</td>
<td align="right">
<sup>IIIP1-P2</sup>K<sup>1419</sup>E</td>
<td align="left">BrS1</td>
<td align="left">NP</td>
<td rowspan="4" align="left"/>
<td rowspan="4" align="left"/>
</tr>
<tr>
<td align="right">
<sup>IP1-P2</sup>W<sup>374</sup>G</td>
<td align="left">BrS1</td>
<td align="left">NP</td>
</tr>
<tr>
<td align="right">
<sup>IP1-P2</sup>Q<sup>371</sup>R</td>
<td align="left">BrS1</td>
<td align="left">VUS</td>
</tr>
<tr>
<td align="right">
<sup>IS6</sup>I<sup>397</sup>T</td>
<td align="left">BrS1, LQT3, NP</td>
<td align="left">CIP</td>
</tr>
<tr>
<td colspan="2" align="right">
<sup>IVS6</sup>M<sup>1766</sup>I</td>
<td align="left">BrS1, CVP</td>
<td align="right">
<sup>IS6</sup>N<sup>406</sup>K</td>
<td align="left">LQT3</td>
<td align="left">P, LP</td>
<td rowspan="5" align="char" char=".">3</td>
<td rowspan="5" align="center">S</td>
</tr>
<tr>
<td colspan="2" align="right">K</td>
<td align="left">NP, BrS1, SSS</td>
<td align="right">
<sup>IS6</sup>N<sup>406</sup>S</td>
<td align="left">BrS1</td>
<td align="left">NP</td>
</tr>
<tr>
<td colspan="2" align="right">V</td>
<td align="left">BrS1</td>
<td align="right">
<sup>IVS5</sup>I<sup>1660</sup>V</td>
<td align="left">A, BrS1, CVP, LQT3</td>
<td align="left">CIP</td>
</tr>
<tr>
<td colspan="2" align="right">T</td>
<td align="left">HCM</td>
<td rowspan="2" align="left"/>
<td rowspan="2" align="left"/>
<td rowspan="2" align="left"/>
</tr>
<tr>
<td colspan="2" align="right">L</td>
<td align="left">LQT3</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="Tfn1">
<label>a</label>
<p>
<italic>See Energy Calculations and Optimization</italic> Section for definition of contacts.</p>
</fn>
<fn id="Tfn2">
<label>b</label>
<p>All PDVs were listed as VUS in ClinVar-2019. In ClinVar-2021, conflicting interpretations of pathogenicity is reported for three variants (R<sup>894</sup>H, G<sup>1262</sup>D, I<sup>1660</sup>V) and two variants (D<sup>197</sup>G, L<sup>225</sup>V) are classified as likely pathogenic.</p>
</fn>
<fn id="Tfn3">
<label>c</label>
<p>Superscripted numbers refer to clinical and experimental studies of the variants. 1. <xref ref-type="bibr" rid="B20">Huang et&#x20;al. (2017)</xref>, 2. <xref ref-type="bibr" rid="B39">Ortiz-Bonnin et&#x20;al. (2016)</xref>, 3. <xref ref-type="bibr" rid="B23">Kapplinger et&#x20;al. (2010)</xref>, 4. <xref ref-type="bibr" rid="B64">Walsh et&#x20;al. (2014)</xref>, 5. <xref ref-type="bibr" rid="B8">Calloe et&#x20;al. (2013)</xref>, 6. <xref ref-type="bibr" rid="B32">Liang et&#x20;al. (2016)</xref>, 7. <xref ref-type="bibr" rid="B53">Son et&#x20;al. (2018)</xref>, 8. <xref ref-type="bibr" rid="B67">Zakliaz&#x2019;minskaia et&#x20;al. (2013)</xref>, 9. <xref ref-type="bibr" rid="B22">Kapplinger et&#x20;al. (2015)</xref>, 10. <xref ref-type="bibr" rid="B43">Rudic et&#x20;al. (2016)</xref>, 11. <xref ref-type="bibr" rid="B48">Shin et&#x20;al. (2004)</xref>, 12. <xref ref-type="bibr" rid="B40">Priganc et&#x20;al. (2017)</xref>, 13. <xref ref-type="bibr" rid="B12">Cordeiro et&#x20;al. (2006)</xref>, 14. <xref ref-type="bibr" rid="B47">Selga et&#x20;al. (2015)</xref>, 15. <xref ref-type="bibr" rid="B36">N&#xfa;&#xf1;ez et&#x20;al. (2013)</xref>, 16. <xref ref-type="bibr" rid="B68">Zeng et&#x20;al. (2016)</xref>, 17. <xref ref-type="bibr" rid="B3">Bodian et&#x20;al. (2017)</xref>, 18. <xref ref-type="bibr" rid="B29">Li et&#x20;al. (2018)</xref>, 19. <xref ref-type="bibr" rid="B4">Brewer et&#x20;al. (2020)</xref>.</p>
</fn>
<fn id="Tfn4">
<label>d</label>
<p>Abbreviations: A, Arrhythmia; AF, atrial fibrillation; BrS1, Brugada syndrome; CA, Cardiac Arrest; CIP, Conflicting interpretations of pathogenicity; CVP, Cardiovascular phenotype; DCM, Dilated cardiomyopathy; HCM, Hypertrophic cardiomyopathy; LP, Likely Pathogenic, LQT3, Long QT syndrome Type 3; M, Multiple diseases; NP, not provided; NR, Variants are not reported in ClinVar; NS, Not Specified; P, Pathogenic; PFHB-1, Progressive Familial Heart Block type 1A; PFVF1, Paroxysmal Familial Ventricular Fibrillation 1; SIDS, Sudden Infant Death Syndrome; VUS, Variant of Uncertain Significance.</p>
</fn>
<fn id="Tfn5">
<label>e</label>
<p>Matching numbers show WT residues that are in contact in the cryo-EM structure.</p>
</fn>
<fn id="Tfn6">
<label>f</label>
<p>state-dependent contacts involving residues that move upon activation gating (located C-terminal to gating-hinge in KcsA).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>PDVs and their contact variants in the open-PD model<xref ref-type="table-fn" rid="Tfn7">
<sup>a</sup>
</xref>.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th colspan="2" align="left">PDV</th>
<th colspan="3" align="center">Contacts</th>
</tr>
<tr>
<th align="left">Variant</th>
<th align="center">Syndrome</th>
<th align="center">Variant</th>
<th align="center">Syndrome</th>
<th align="center">Significance</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="3" align="left">
<sup>IIIS6</sup>N<sup>1463</sup>K</td>
<td rowspan="3" align="left">NP</td>
<td align="left">
<sup>IIS6</sup>S<sup>94</sup>&#xb0;C</td>
<td align="left">BrS1</td>
<td align="left">VUS</td>
</tr>
<tr>
<td align="left">
<sup>IIS6</sup>S<sup>941</sup>C</td>
<td align="left">CP</td>
<td align="left">VUS</td>
</tr>
<tr>
<td align="left">N</td>
<td align="left">LQT3</td>
<td align="left">P</td>
</tr>
<tr>
<td rowspan="2" align="left">
<sup>IIIS6</sup>F<sup>1465</sup>L</td>
<td rowspan="2" align="left">LQT3</td>
<td align="left">
<sup>IIIS5</sup>A<sup>1330</sup>P</td>
<td align="left">LQT3</td>
<td align="left">NP</td>
</tr>
<tr>
<td align="left">T</td>
<td align="left">BrS1, LQT3, More</td>
<td align="left">P/LP</td>
</tr>
<tr>
<td align="left">
<sup>IIIS6</sup>I<sup>1466</sup>T</td>
<td align="left">NP, A</td>
<td align="left">
<sup>IIS6</sup>S<sup>941</sup>C</td>
<td align="left">CP</td>
<td align="left">VUS</td>
</tr>
<tr>
<td align="left">V</td>
<td align="left">NP</td>
<td align="left">N</td>
<td align="left">LQT3</td>
<td align="left">P</td>
</tr>
<tr>
<td rowspan="2" align="left">
<sup>IIIS6</sup>V<sup>1468</sup>A</td>
<td rowspan="2" align="left">A, BrS1,NP</td>
<td align="left">
<sup>IIIS5</sup>A<sup>1330</sup>P</td>
<td align="left">LQT3</td>
<td align="left">NP</td>
</tr>
<tr>
<td align="left">T</td>
<td align="left">BrS1, LQT3, More</td>
<td align="left">P/LP</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="Tfn7">
<label>a</label>
<p>Contacts in the cryo-EM structure (<xref ref-type="table" rid="T1">Table&#x20;1</xref>) are not&#x20;shown.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3-2">
<title>Matrices of Contact Variants</title>
<p>To facilitate recognition of disease-related contacts, we schematically represented them in colored matrices. Each matrix represents an individual domain because inter-domain contacts of PDVs are rare. A matrix of contact variants for the inactivated PD (<xref ref-type="fig" rid="F1">Figure&#x20;1</xref>) has four bottom rows, which represent PDVs, their location, and clinical significance; four left columns represent analogous characteristics of contact variants of PDVs. Variants associated with BrS1, LQT3 or non-specified arrhythmia are colored pink, green or yellow, respectively. Variants associated with other diseases are not colored. Variants, which are associated with more than one disease, are shown with two colors. Each cell in the matrix body links a PDV and its contact variant.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Matrix of contact variants in the PD cryo-EM. Bottom rows (X1-X4) represent w54 residues and their PDVs. X1 and X2 show PD segments and UniProt residue numbers. X3 shows one-letter codes of WT residues and their variants. X4 indicates clinical significance of variants. Variants associated with BrS1, LQT3, non-specified Arrhythmias or other diseases are colored, respectively, pink, green, yellow, or not colored. If besides BrS1 or LQT3, a variant is associated with a non-specified arrhythmia, it is colored pink or green, respectively. If various diseases are reported for a variant, two colors are used. Left columns (Y1-Y4) show analogous features of contact variants of w54 residues. A colored cell in the matrix body links a PDV and its contact variant. If a WT residue has <italic>m</italic> PDVs and <italic>n</italic> contacts variants, a cluster of <italic>m x n</italic> colored cells shows all variant combinations. If PDV and its contact variant have the same color, it is applied to the cell. If a cell links pink and yellow variants, it is colored pink. If a cell links green and yellow variants, it is colored green. If a variant has color A and its contact variants colors A and B, color A is applied to the cell. Otherwise the cell is grey. If a residue is located in cytoplasmic halves of S6 helices, which move upon the channel gating, respective cell is bold-boxed.</p>
</caption>
<graphic xlink:href="fphar-12-756415-g001.tif"/>
</fig>
<p>The matrix highlighted multiple contacts where mutation of either WT residue is associated with the same syndrome. A likely cause is that a disease-related contact contributes to stabilization (or destabilization) of a particular channel state; a weakened or strengthened contact would similarly affect the channel state stability regardless of the mutated contact partner. Structural analysis of all contacts involving PDVs is beyond goals of this study. Below we propose mechanisms of dysfunction for some PDVs and their contact variants.</p>
</sec>
<sec id="s3-3">
<title>Contacts in P-Loops</title>
<p>In our models with the closed and open PD, which are described in a later section, conformations of P-loops are rather similar to those in the cryo-EM structure. And although P-loops do undergo conformational changes, e.g., upon slow inactivation, here we consider their folding as relatively state-independent. <xref ref-type="fig" rid="F2">Figure&#x20;2</xref> shows P-loops with some contacts, which apparently stabilize their folding and a matrix of respective contacts variants. Five hydrophobic residues (<sup>IS6</sup>M<sup>390</sup>, <sup>IS6</sup>M<sup>397</sup>, <sup>IVS5</sup>M<sup>1668</sup>, <sup>IVP1</sup>M<sup>1701</sup>, and L<sup>1704</sup>) form a tight cluster (<xref ref-type="fig" rid="F2">Figures 2A,B</xref>). In variants M<sup>390</sup>I/V, M<sup>394</sup>I, M<sup>1668</sup>T, and M<sup>1701</sup>I, methionine substitutions with smaller residues (<xref ref-type="fig" rid="F2">Figure&#x20;2C</xref>) would relax the cluster and increase flexibility of the smallest involved helix, IVP1. Substitutions <sup>IVP1</sup>L<sup>1704</sup>H and <sup>IS6</sup>I<sup>397</sup>T would also increase flexibility of this helix. The C-end of helix IVP1 approaches the DEKA-ring alanine in the SF region (<xref ref-type="fig" rid="F2">Figure&#x20;2B</xref>), which harbors the SF gate. The outer-pore of a prokaryotic sodium channel exhibits flexibility during slow inactivation (<xref ref-type="bibr" rid="B10">Chatterjee et&#x20;al., 2018</xref>). In the Nav1.4 channel, the P-loop of domain IV is more flexible than in other domains (<xref ref-type="bibr" rid="B60">Tsushima et&#x20;al., 1997a</xref>; <xref ref-type="bibr" rid="B61">Tsushima et&#x20;al., 1997b</xref>). The above mutations would increase flexibility of helix IVP1, disturb the SF gate, and facilitate the channel transition to the slow-inactivated state. This proposition is supported by the fact that most substitutions in P-loops are associated with the loss-of-function syndromes, especially with BrS1 (<xref ref-type="fig" rid="F2">Figure&#x20;2C</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Residue contacts that stabilize P-loops in the cryo-EM structure. Backbones and sidechain carbon atoms in repeats I, II, III and IV are yellow, pink, green and gray, respectively. Residues w54 and their contacts are indicated with green and red labels, respectively. <bold>(A,B)</bold> Intra-membrane views of P-loops in the cryo-EM structure. Residues M<sup>390</sup>, M<sup>394</sup>, M<sup>1668</sup>, M<sup>1701</sup> and L<sup>1704</sup> form a tight hydrophobic cluster, which apparently stabilizes mutual disposition of helices IS6, IVS5 and IVP1. <bold>(C)</bold> Matrix of contact variants in P-loops. Majority of coupled variants are associated with BrS1 and arrhythmia, which also may be a loss-of-function disease. <bold>(D)</bold> Intra-membrane view of helices IIP1 and IIP2 whose mutual disposition is stabilized by salt bridge R<sup>893</sup>:E<sup>901</sup>. Side-chain conformation of the selectivity-filter DEKA glutamate E<sup>901</sup> is stabilized by its salt bridge with R<sup>898</sup>. Helical structure of helix IIP1 is stabilized by &#x3c0;-stacking F<sup>888</sup> and F<sup>892</sup>. <bold>(E)</bold> Intra-membrane view of helices IIIP1 and IIIP2 whose mutual disposition is stabilized by a cluster of four hydrophobic residues. The selectivity-filter DEKA lysine K<sup>1419</sup> is shown by sticks. <bold>(F)</bold> Extracellular view of salt bridges R<sup>383</sup>:D<sup>1690</sup>, R<sup>893</sup>:E<sup>901</sup> and hydrophobic contacts I<sup>397</sup>:T1<sup>709</sup>, L<sup>1342</sup>:Y<sup>1409</sup> and I<sup>1424</sup>:F<sup>1360</sup>.</p>
</caption>
<graphic xlink:href="fphar-12-756415-g002.tif"/>
</fig>
<p>Several other mutations involving P-loops would also increase their flexibility. For example, in the cryo-EM structure, <sup>IIP1</sup>F<sup>892</sup> and <sup>IIP1</sup>F<sup>888</sup> form a stacking pair (<xref ref-type="fig" rid="F2">Figure&#x20;2D</xref>) that can stabilize the&#x20;&#x3b1;-helix (<xref ref-type="bibr" rid="B7">Butterfield et&#x20;al., 2002</xref>). Mutation <sup>IIP1</sup>F<sup>892</sup>L affects the inter-segment contact with <sup>IIIS6</sup>V<sup>1451</sup> (<xref ref-type="table" rid="T1">Table&#x20;1</xref>) and destroys the stacking pair with likely destabilization of helix IIP1. A sequential neighbor of F<sup>892</sup>, <sup>IIP1</sup>R<sup>893</sup> forms several strong contacts, including a salt bridge with <sup>IIP2</sup>E<sup>901</sup>, which stabilizes mutual disposition of helices IIP1 and IIP2 (<xref ref-type="fig" rid="F2">Figure&#x20;2D</xref>). Substitution of any partner in the salt bridge is associated with BrS1 (<xref ref-type="fig" rid="F2">Figure&#x20;2C</xref>) likely due to destabilization of mutual disposition of helices IIP1 and IIP2. Another strong contact of <sup>IIP1</sup>R<sup>893</sup> involves the SF glutamate <sup>IIP1-P2</sup>E<sup>898</sup>, which is proposed to adopt multiple conformations in a cycle of sodium ion permeation (<xref ref-type="bibr" rid="B69">Zhorov, 2021</xref>). The cryo-EM structure of Nav1.5 is obtained in complex with quinidine that favors inactivated channels (<xref ref-type="bibr" rid="B30">Li et&#x20;al., 2021</xref>). However, it is unknown whether the SF gate is captured in the open or closed state. A strong electrostatic attraction to <sup>IIP1</sup>R<sup>893</sup> may stabilize the E<sup>898</sup> conformation in the slow-inactivated&#x20;state.</p>
<p>Several other contacts also stabilize folding of P-loops. An example is a knob-into-hole contact <sup>IIIP2</sup>I<sup>1424</sup> : <sup>IIIP1</sup>A<sup>1411</sup> that stabilizes the mutual disposition of helices IIIP1 and IIIP2 with the selectivity-filter lysine <sup>IIIP1-P2</sup>K<sup>1419</sup> (<xref ref-type="fig" rid="F2">Figure&#x20;2E</xref>). Mutation I<sup>1424</sup>F affects contact with A<sup>1411</sup>, as well as contacts with <sup>IIIS5-P1</sup>F<sup>1360</sup> and <sup>IIIS5-P1</sup>V<sup>1400</sup> whose variants are associated with diseases (<xref ref-type="table" rid="T1">Table&#x20;1</xref>). Another example is a salt bridge <sup>IVS5-P1</sup>D<sup>1690</sup> : <sup>IP2</sup>R<sup>383</sup> (<xref ref-type="fig" rid="F2">Figures 2A,F</xref>), which is absent in BrS1-associated variants <sup>IVS5-P1</sup>D<sup>1690</sup>N and R<sup>383</sup>K. In a functional study, variant D<sup>1690</sup>N reduced I<sub>Na</sub> and shifted the steady-state activation by &#x2b;7&#xa0;mV (<xref ref-type="bibr" rid="B68">Zeng et&#x20;al., 2016</xref>).</p>
<p>Thus, majority of mutations affecting the P1 and P2 helices are associated with the loss-of-function BrS1. Apparently these mutations distort the SF gate and increase population of slow-inactivated channels. For comparison, two residues beyond P1 and P2 helices, <sup>IIS5-P1</sup>M<sup>881</sup> and <sup>IIS5</sup>G<sup>857</sup>, form a knob-into-hole contact that would not directly affect the SF region. Both <sup>IIS5-P1</sup>M<sup>881</sup>I and <sup>IIS5</sup>G<sup>857</sup>D are PDVs (<xref ref-type="table" rid="T1">Table&#x20;1</xref>). However, unlike the above-described BrS1-associated variants that affect folding of P-helices, M<sup>881</sup>I is associated with the gain-of-function LQT3, while G<sup>857</sup>D is associated with&#x20;BrS1.</p>
</sec>
<sec id="s3-4">
<title>Contacts in the Channel Models with the Open and Closed PD</title>
<p>
<xref ref-type="fig" rid="F3">Figures 3A&#x2013;C</xref> show cytoplasmic views of the PD, respectively, in the cryo-EM structure, closed state, and open state. Space-filled hydrophobic residues at the cytoplasmic ends of S6 helices highlight different dimensions of the activation gate in these states. <xref ref-type="fig" rid="F3">Figure&#x20;3D</xref> shows intra-membrane view of the full-fledged channel model with the open PD and activated VSDs. PDVs and respective contact variants, which are specific for the models with the closed PD and open PD, are presented in <xref ref-type="table" rid="T2">Tables 2</xref>,&#x20;<xref ref-type="table" rid="T3">3</xref>.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Cryo-EM structure and homology model of the hNav1.5 channel. Repeats I,II, III and IV are yellow, pink, green and gray, respectively. <bold>(A, C)</bold> Cytoplasmic views at the pore domain in the cryo-EM structure <bold>(A)</bold>, and NavAb-based models of the channel states with the closed <bold>(B)</bold> and open <bold>(C)</bold> pore domain. Space-filled residues at the cytoplasmic ends of S6 helices highlight different dimensions of the activated gate. <bold>(D)</bold> Intra-membrane view of the channel model with the open PD.</p>
</caption>
<graphic xlink:href="fphar-12-756415-g003.tif"/>
</fig>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>PDVs and their contact variants in the closed-PD model<xref ref-type="table-fn" rid="Tfn8">
<sup>a</sup>
</xref>.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th colspan="2" align="left">PDV</th>
<th colspan="3" align="center">Contacts</th>
</tr>
<tr>
<th align="left">Variant</th>
<th align="center">Syndrome</th>
<th align="center">Variant</th>
<th align="center">Syndrome</th>
<th align="center">Signif</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">
<sup>IS6</sup>A<sup>413</sup>E</td>
<td align="left">LQT3</td>
<td align="center">
<sup>IVS6</sup>N<sup>1774</sup>D</td>
<td align="left">LQT3</td>
<td align="left">NP</td>
</tr>
<tr>
<td align="left">S</td>
<td align="left">NS</td>
<td align="center">S</td>
<td align="left">BrS1</td>
<td align="left">NP</td>
</tr>
<tr>
<td align="left">T</td>
<td align="left">A, LQT3,BrS1</td>
<td align="center">Y</td>
<td align="left">NS</td>
<td align="left">CIP</td>
</tr>
<tr>
<td rowspan="2" align="left">
<sup>IIIS6</sup>N<sup>1463</sup>K</td>
<td rowspan="2" align="left">NP</td>
<td align="center">
<sup>IIS5</sup>S<sup>835</sup>L</td>
<td align="left">BrS1</td>
<td align="left">NP</td>
</tr>
<tr>
<td align="center">A</td>
<td align="left">BrS1</td>
<td align="left">VUS</td>
</tr>
<tr>
<td align="left">
<sup>IIIS6</sup>F<sup>1465</sup>L</td>
<td align="left">LQT3</td>
<td align="center">
<sup>IVS6</sup>I<sup>1768</sup>V</td>
<td align="left">BrS1, LQT3</td>
<td align="left">P</td>
</tr>
<tr>
<td rowspan="3" align="left">
<sup>IIIS6</sup>I<sup>1469</sup>F</td>
<td rowspan="3" align="left">NP</td>
<td align="center">
<sup>IVS6</sup>I<sup>1768</sup>V</td>
<td align="left">BrS1, LQT3</td>
<td align="left">P</td>
</tr>
<tr>
<td align="center">
<sup>IVS6</sup>L<sup>1772</sup>P</td>
<td align="left">BrS1</td>
<td align="left">VUS</td>
</tr>
<tr>
<td align="center">V</td>
<td align="left">LQT3</td>
<td align="left">NP</td>
</tr>
<tr>
<td align="left">
<sup>IVS6</sup>M<sup>1766</sup>I</td>
<td align="left">CVP, BrS1</td>
<td rowspan="5" align="center">
<sup>IVS6</sup>G<sup>1661</sup>R</td>
<td rowspan="5" align="left">BrS1</td>
<td rowspan="5" align="left">NP, CIP</td>
</tr>
<tr>
<td align="left">K</td>
<td align="left">NP, BrS1, SSS</td>
</tr>
<tr>
<td align="left">V</td>
<td align="left">BrS1</td>
</tr>
<tr>
<td align="left">T</td>
<td align="left">HCM</td>
</tr>
<tr>
<td align="left">L</td>
<td align="left">LQT3</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="Tfn8">
<label>a</label>
<p>Contacts in the cryo-EM structure (<xref ref-type="table" rid="T1">Table&#x20;1</xref>) are not&#x20;shown.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>
<xref ref-type="fig" rid="F4">Figure&#x20;4A</xref> shows matrix of contact variants in the cytoplasmic halves of TM helices of the open PD. A hydrophobic cluster involving <sup>IIIS5</sup>A<sup>1330</sup>, <sup>IIIS5</sup>I<sup>1334</sup>, <sup>IIIS6</sup>F<sup>1465</sup>, <sup>IIIS6</sup>V<sup>1468</sup> and <sup>IVS6</sup>L<sup>1761</sup> (<xref ref-type="fig" rid="F4">Figure&#x20;4B</xref>) apparently stabilizes the open PD. Substitutions of A<sup>1330</sup> with bigger proline or threonine, or substitution of F<sup>1465</sup> with more flexible leucine are associated with the gain-of-function LQT3 likely because respective variants over-stabilize the open PD. In LQT3-associated variants L<sup>1761</sup>H/F, the open state of PD would be stabilized due to &#x3c0;-stacking of the aromatic substitutions with F<sup>1465</sup>.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Open and closed conformations of PD. <bold>(A&#x2013;C)</bold> Open PD model. <bold>(A)</bold> Matrix of contact variants shows only those PDVs and their contacts, which are unique in the open PD model. Most of coupled variants are associated with either BrS1 or LQT3. (<bold>B)</bold> Hydrophobic contacts L<sup>1761</sup>:F<sup>1465</sup>:F<sup>1760</sup> and A<sup>1330</sup>:V<sup>1468</sup>:I<sup>1334</sup> stabilize, respectively, mutual disposition of helices IIIS6/IVS6 and IIIS5/IIIS6. <bold>(C)</bold> H-bond S<sup>941</sup>:N<sup>1463</sup> stabilizes mutual disposition of helices IIS6/IIIS6. <bold>(D&#x2013;F)</bold> Closed PD model. <bold>(D)</bold> Matrix of contact variants shows only those PDV and their contacts, which are unique in the closed-PD model. <bold>(E)</bold> Mutual disposition of helices IIIS6 and IVS6 in the closed PD is stabilized by hydrophobic contacts F<sup>1465</sup>:L<sup>1761</sup> with side chain conformations different from those in the open-PD model. In coupled LQT3-associated variants, substitutions F<sup>1465</sup>L or L<sup>1761</sup>F/H would destabilize the closed PD. Mutual disposition of helices IVS5/IVS6 is stabilized by a hydrophobic contact M<sup>1761</sup>:I<sup>1660</sup> and a knob-into-hole contact M<sup>1761</sup>:G<sup>1661</sup>. <bold>(F)</bold> Mutual disposition of helices IS6/IVS6 is stabilized by a tight hydrophobic contact between A<sup>413</sup> and methylene group of N<sup>1774</sup>. Replacement of any contact partner with a large residue would destabilize the closed PD, a likely cause of LQT3 associated with these mutations.</p>
</caption>
<graphic xlink:href="fphar-12-756415-g004.tif"/>
</fig>
<p>Variant <sup>IVS6</sup>F<sup>1760</sup>C is associated with BrS1. In functional studies, F<sup>1760</sup>C impaired fast inactivation, accelerated recovery from inactivation (<xref ref-type="bibr" rid="B9">Carboni et&#x20;al., 2005</xref>; <xref ref-type="bibr" rid="B37">O&#x27;Leary and Chahine, 2015</xref>), and enhanced slow inactivation (<xref ref-type="bibr" rid="B9">Carboni et&#x20;al., 2005</xref>). Mutant channel F<sup>1760</sup>A, which is used as a model for drug binding assays, causes a &#x223c; 20&#xa0;mV depolarizing shift of steady-state inactivation (<xref ref-type="bibr" rid="B9">Carboni et&#x20;al., 2005</xref>). LQT3-associated mutation A<sup>1330</sup>P increased the window current, whereas mutation A<sup>1330</sup>T, which is associated with LQT3, BrS1 and other diseases, increased the window current, impaired inactivation and accelerated recovery from inactivation (<xref ref-type="bibr" rid="B52">Smits et&#x20;al., 2005b</xref>).</p>
<p>
<xref ref-type="fig" rid="F4">Figure&#x20;4C</xref> shows the H-bond between <sup>IIIS6</sup>N<sup>1463</sup> and <sup>IIS6</sup>S<sup>941</sup> that is specific for the open PD. This is an example of inter-repeat H-bonds involving asparagine residues, which are exceptionally conserved in sodium and calcium channels. Earlier such H-bonds were predicted (<xref ref-type="bibr" rid="B57">Tikhonov et&#x20;al., 2015</xref>) and demonstrated (<xref ref-type="bibr" rid="B14">Du et&#x20;al., 2018</xref>) to stabilize the open conformations of these channels. LQT3-associated variant S<sup>941</sup>N would over-stabilize the H-bond and hence the open state of PD, whereas variant S<sup>941</sup>C, which is associated with a non-specific cardiovascular phenotype, may destabilize the H-bond and thus the channel open state. Variant S<sup>941</sup>N was found in an infant died from the sudden infant death syndrome, the disease associated with both Nav1.5 gain-of-function and loss-of-function (<xref ref-type="bibr" rid="B1">Amin et&#x20;al., 2010</xref>). The mutant channel S<sup>941</sup>N expressed in <italic>Xenopus</italic> oocytes demonstrated the increased late current (<xref ref-type="bibr" rid="B46">Schwartz et&#x20;al., 2000</xref>).</p>
<p>Contacts between cytoplasmic halves of TM helices in the closed PD are summarized in matrix shown in <xref ref-type="fig" rid="F4">Figure&#x20;4D</xref>. Some open-PD contacts, e.g., <sup>IVS6</sup>L<sup>1761</sup> : <sup>IIIS6</sup>F<sup>1465</sup>, are also seen in the closed PD, but the residue orientations in the two models are substantially different (cf. <xref ref-type="fig" rid="F4">Figures 4B, E</xref>). A knob-into-hole contact <sup>IVS6</sup>M<sup>1766</sup> : <sup>IVS5</sup>G<sup>1661</sup>, which is seen only in the closed-PD model (<xref ref-type="table" rid="T3">Table&#x20;3</xref>), and hydrophobic contact <sup>IVS6</sup>M<sup>1766</sup> : <sup>IVS5</sup>I<sup>1660</sup> (<xref ref-type="fig" rid="F4">Figure&#x20;4E</xref>) apparently stabilize the closed PD conformation. It would be destabilized in LQT3-associated variants M<sup>1766</sup>L and I<sup>1660</sup>V where large hydrophobic residues are substituted with smaller ones. In functional studies, mutation I<sup>1660</sup>V decreased the current, which was rescued by 48&#xa0;h incubation at room temperature or by mexiletine; the variant was suggested to affect the channel folding, while mexiletine or room temperature stabilized the folding (<xref ref-type="bibr" rid="B12">Cordeiro et&#x20;al., 2006</xref>). Mutation M<sup>1766</sup>L significantly decreased the sodium channel expression, which was partially rescued by mexiletine; however, this mutation also demonstrated a 10-fold increase of the persistent late sodium current (<xref ref-type="bibr" rid="B62">Valdivia et&#x20;al., 2002</xref>).</p>
<p>A tight contact between <sup>IS6</sup>A<sup>413</sup> and the methylene group of <sup>IVS6</sup>N<sup>1774</sup> is seen only in the closed-PD model (<xref ref-type="table" rid="T3">Table&#x20;3</xref> and <xref ref-type="fig" rid="F4">Figure&#x20;4F</xref>). Substitution of either contact partner with a larger residue would destabilize the closed conformation, resulting in LQT3 (<xref ref-type="fig" rid="F4">Figure&#x20;4D</xref>). Mutant channel N<sup>1774</sup>D expressed in the CHO-K1 cells demonstrated increased peak sodium current density, late current and enhanced activation (<xref ref-type="bibr" rid="B24">Kato et&#x20;al., 2014</xref>). Similar electrophysiological changes, as well as markedly increased duration of the action potential, were found in the cardiac myocytes derived from induced pluripotent stem cells from a boy with LQT3-associated mutation N<sup>1774</sup>D (<xref ref-type="bibr" rid="B18">Hirose et&#x20;al., 2020</xref>). Variant N<sup>1774</sup>S was found in a Chinese family with BrS1 (<xref ref-type="bibr" rid="B13">Du et&#x20;al., 2005</xref>).</p>
<p>In the cryo-EM structure, <sup>IIIS6</sup>F<sup>1465</sup> forms hydrophobic contacts with four residues whose three variants are associated with LQT3 (<xref ref-type="table" rid="T1">Table&#x20;1</xref>). In our closed-PD model, <sup>IVS6</sup>I<sup>1768</sup> forms a tight contact with F<sup>1465</sup> whose substitution F<sup>1465</sup>L is also associated with LQT3 (<xref ref-type="table" rid="T3">Table&#x20;3</xref>). Substitutions F<sup>1465</sup>L or I<sup>1768</sup>V would destabilize the hydrophobic contact and thus the closed conformation of PD. LQT3-associated substitution I<sup>1768</sup>V would weaken contacts that stabilize both the inactivated and closed-state conformation of the PD. In functional studies, mutant channel I<sup>1768</sup>V accelerated recovery from inactivation and increased the channel availability (<xref ref-type="bibr" rid="B42">Rivolta et&#x20;al., 2002</xref>). In another study, mutant channel I<sup>1768</sup>V accelerated recovery from inactivation, impaired slow inactivation, but did not affect steady-state activation and inactivation (<xref ref-type="bibr" rid="B17">Groenewegen et&#x20;al., 2003</xref>).</p>
</sec>
<sec id="s3-5">
<title>Contacts in VSDs</title>
<p>PDVs and their contacts in the cryo-EM structure with the activated VSDs and models with resting PDVs are shown in <xref ref-type="table" rid="T4">Tables 4</xref>, <xref ref-type="table" rid="T5">5</xref>, respectively. Many contacts switch upon VSD transitions between the activated-state conformations, which are captured in the cryo-EM structure, and resting-state models. We summarized these contacts in four matrices (<xref ref-type="fig" rid="F5">Figures 5</xref>&#x2013;<xref ref-type="fig" rid="F7">7</xref>) where cells are labeled &#x201c;C&#x201d;, &#x201c;M&#x201d; or &#x201c;B&#x201d; depending on whether respective contacts are seen only in the cryo-EM structure, only in the resting-state model, or both in the cryo-EM structure and the model. It should be noted that ionized residues in VSDs switch contacts during channel gating. Impact of mutations in such contacts on relative stability of different channel states is difficult to predict. On the other hand, respective contacts are promising targets for further studies.</p>
<table-wrap id="T4" position="float">
<label>TABLE 4</label>
<caption>
<p>PDVs and their contacts in activated VSDs<sup>a</sup>.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th colspan="2" align="left">PDVs</th>
<th colspan="5" align="center">Contacts</th>
</tr>
<tr>
<th align="left">Variant<sup>b</sup>
</th>
<th align="center">Syndrome<sup>c</sup>
</th>
<th align="center">Mutation</th>
<th align="center">Syndrome<sup>d</sup>
</th>
<th align="center">Significance</th>
<th align="center">
<sup>e</sup>
</th>
<th align="center">
<sup>f</sup>
</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">
<sup>IS1</sup>M<sup>138</sup>I</td>
<td align="left">AF</td>
<td align="center">
<sup>IS4</sup>T<sup>229</sup>S</td>
<td align="left">BrS1</td>
<td align="center">VUS</td>
<td rowspan="2" align="left"/>
<td align="center">S</td>
</tr>
<tr>
<td align="left">T</td>
<td align="left">DCM<sup>1</sup>
</td>
<td align="center">
<sup>IS4-S5</sup>V<sup>232</sup>I</td>
<td align="left">A, BrS1, CVP</td>
<td align="center">CIP</td>
<td align="center">S</td>
</tr>
<tr>
<td align="left">
<sup>IS1</sup>I<sup>141</sup>N</td>
<td align="left">BrS1</td>
<td align="center">
<sup>IS4</sup>T<sup>229</sup>S</td>
<td align="left">BrS1</td>
<td align="center">VUS</td>
<td rowspan="6" align="left"/>
<td align="center">S</td>
</tr>
<tr>
<td rowspan="5" align="left">F</td>
<td rowspan="5" align="left">NS</td>
<td align="center">
<sup>IS4</sup>R<sup>225</sup>Q</td>
<td align="left">BrS1, LQT3, More</td>
<td align="center">CIP</td>
<td align="center">S</td>
</tr>
<tr>
<td align="center">W</td>
<td align="left">BrS1, LQT3, More</td>
<td align="center">P/LP</td>
<td align="center">S</td>
</tr>
<tr>
<td align="center">
<sup>IS4</sup>A<sup>226</sup>D</td>
<td align="left">BrS1</td>
<td align="center">VUS</td>
<td rowspan="3" align="center">S</td>
</tr>
<tr>
<td align="center">V</td>
<td align="left">BrS1, LQT3, More</td>
<td align="center">CIP</td>
</tr>
<tr>
<td align="center">
<sup>IS4</sup>V<sup>232</sup>I</td>
<td align="left">A, BrS1, CVP</td>
<td align="center">CIP</td>
</tr>
<tr>
<td align="left">
<sup>IS2</sup>R<sup>179</sup>P</td>
<td align="left">BrS1</td>
<td align="center">
<sup>IS1</sup>L<sup>128</sup>P</td>
<td align="left">BrS1</td>
<td align="center">VUS</td>
<td rowspan="4" align="center">4</td>
<td rowspan="4" align="left"/>
</tr>
<tr>
<td rowspan="3" align="left">Q</td>
<td rowspan="3" align="left">BrS1</td>
<td align="center">
<sup>IS2-S3</sup>T<sup>187</sup>S</td>
<td align="left">BrS1</td>
<td align="center">VUS</td>
</tr>
<tr>
<td align="center">I</td>
<td align="left">BrS1</td>
<td align="center">NP</td>
</tr>
<tr>
<td align="center">A</td>
<td align="left">BrS1, CA</td>
<td align="center">CIP</td>
</tr>
<tr>
<td align="left">
<sup>IS2-S3</sup>T<sup>187</sup>S</td>
<td align="left">BrS1</td>
<td align="center">
<sup>IS2</sup>R<sup>179</sup>P</td>
<td align="left">BrS1</td>
<td align="center">VUS</td>
<td align="center">4</td>
<td align="left"/>
</tr>
<tr>
<td align="left">I</td>
<td align="left">BrS1, NP</td>
<td align="center">Q</td>
<td align="left">BrS1</td>
<td rowspan="2" align="center">VUS</td>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">A</td>
<td align="left">BrS1</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">
<sup>IS3</sup>D<sup>197</sup>G</td>
<td align="left">BrS1</td>
<td align="center">
<sup>IS2</sup>K<sup>175</sup>D</td>
<td align="left">BrS1</td>
<td align="center">NP</td>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">H</td>
<td align="left">BrS1</td>
<td align="center">
<sup>IS2</sup>E<sup>171</sup>G</td>
<td align="left">BrS1</td>
<td align="center">VUS</td>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Y</td>
<td align="left">DCM</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">
<sup>IIS3</sup>E<sup>795</sup>K</td>
<td align="left">BrS1</td>
<td align="center">
<sup>IIS4</sup>L<sup>807</sup>P</td>
<td align="left">BrS1, NP</td>
<td align="center">VUS</td>
<td align="left"/>
<td align="center">S</td>
</tr>
<tr>
<td align="left">
<sup>IIS4-S5</sup>L<sup>825</sup>P</td>
<td align="left">BrS1</td>
<td align="center">
<sup>IIS4</sup>F<sup>816</sup>L</td>
<td align="left">A</td>
<td align="center">VUS</td>
<td align="left"/>
<td align="center">S</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="center">Y</td>
<td align="left">LQT3</td>
<td align="center">NP</td>
<td align="left"/>
<td align="left">S</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="center">
<sup>IIIS5</sup>V<sup>1340</sup>L</td>
<td align="left">CVP</td>
<td align="center">VUS</td>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="center">I</td>
<td align="left">NP, BrS1, A</td>
<td align="center">VUS</td>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td rowspan="3" align="left">
<sup>IIS5</sup>I<sup>848</sup>F</td>
<td rowspan="3" align="left">A,BrS1, LQT3<sup>1</sup>
</td>
<td align="center">
<sup>IS4</sup>A<sup>226</sup>V</td>
<td align="left">BrS1, LQT3, More</td>
<td align="center">CIP</td>
<td rowspan="3" align="left"/>
<td align="center">S</td>
</tr>
<tr>
<td align="center">D</td>
<td align="left">BrS1</td>
<td align="center">VUS</td>
<td rowspan="2" align="center">S</td>
</tr>
<tr>
<td align="center">
<sup>IS4</sup>I<sup>230</sup>T</td>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">
<sup>IIIS1</sup>A<sup>1221</sup>V</td>
<td align="left">A, BrS1</td>
<td align="center">
<sup>IIIS2</sup>L<sup>1239</sup>P</td>
<td align="left">BrS1</td>
<td align="center">NP</td>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">
<sup>IIIS4</sup>R<sup>1306</sup>L</td>
<td align="left">CVP</td>
<td align="center">
<sup>IIIS2</sup>D<sup>1243</sup>E</td>
<td align="left">BrS1</td>
<td align="center">VUS</td>
<td rowspan="4" align="left"/>
<td align="center">S</td>
</tr>
<tr>
<td align="left">H</td>
<td align="left">NP, BrS1</td>
<td align="center">NG</td>
<td align="left">BrS1, More</td>
<td align="center">VUS</td>
<td align="center">S</td>
</tr>
<tr>
<td align="left">C</td>
<td align="left">A</td>
<td align="center">
<sup>IIIS2</sup>E<sup>1225</sup>K</td>
<td align="left">BrS1</td>
<td align="center">VUS</td>
<td align="center">S</td>
</tr>
<tr>
<td align="left">S</td>
<td align="left">BrS1</td>
<td align="left"/>
<td align="left">LQT3, BrS1, A</td>
<td align="center">VUS</td>
<td align="center">S</td>
</tr>
<tr>
<td align="left">
<sup>IIIS4</sup>R<sup>1316</sup>L</td>
<td align="left">BrS1</td>
<td align="center">
<sup>IIIS1</sup>E<sup>1208</sup>K</td>
<td align="left">A, NP</td>
<td align="center">VUS</td>
<td align="left"/>
<td align="center">S</td>
</tr>
<tr>
<td align="left">Q</td>
<td align="left">BrS1</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">
<sup>IVS2</sup>E<sup>1574</sup>K</td>
<td align="left">BrS1<sup>1,3</sup>
</td>
<td align="center">
<sup>IVS1</sup>I<sup>1534</sup>S</td>
<td align="left">LQT3</td>
<td align="center">VUS</td>
<td rowspan="5" align="left"/>
<td rowspan="5" align="center">S</td>
</tr>
<tr>
<td align="left">
<sup>IVS2</sup>C<sup>1575</sup>Y</td>
<td align="left">A, BrS1</td>
<td rowspan="2" align="center">
<sup>IVS3</sup>F<sup>1596</sup>I</td>
<td rowspan="2" align="left">LQT3, BrS1, More</td>
<td rowspan="2" align="center">VUS</td>
</tr>
<tr>
<td align="left">S</td>
<td align="left">A</td>
</tr>
<tr>
<td align="left">
<sup>IVS3</sup>N<sup>1592</sup>Y</td>
<td align="left">BrS1</td>
<td align="center">
<sup>IVS4</sup>R<sup>1638</sup>P</td>
<td align="left">NP</td>
<td align="center">LP</td>
</tr>
<tr>
<td align="left">
<sup>IVS4-S5</sup>I<sup>1643</sup>L</td>
<td align="left">NP</td>
<td align="center">
<sup>IVS3</sup>I<sup>1637</sup>T</td>
<td align="left">NS</td>
<td align="center">VUS</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>
<sup>a-e</sup> footnotes to <xref ref-type="table" rid="T1">Table&#x20;1</xref>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T5" position="float">
<label>TABLE 5</label>
<caption>
<p>PDVs and their contacts in resting VSDs<xref ref-type="table-fn" rid="Tfn9">
<sup>a</sup>
</xref>.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th colspan="2" align="left">PDV</th>
<th colspan="3" align="center">Contacts</th>
</tr>
<tr>
<th align="left">Variant</th>
<th align="center">Syndrome</th>
<th align="center">Variant</th>
<th align="center">Syndrome</th>
<th align="center">Signif.</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">
<sup>IS1</sup>I<sup>141</sup>N</td>
<td align="left">BrS1</td>
<td align="center">
<sup>IS4</sup>V<sup>223</sup>A</td>
<td align="left">A</td>
<td align="left">LB</td>
</tr>
<tr>
<td align="left">F</td>
<td align="left">NP</td>
<td align="center">L</td>
<td align="left">BrS1</td>
<td align="left">NP</td>
</tr>
<tr>
<td align="left">
<sup>IS2</sup>R<sup>179</sup>P</td>
<td align="left">BrS1</td>
<td align="center">
<sup>IS2-S3</sup>H<sup>184</sup>Q</td>
<td align="left">BrS1, CVP</td>
<td align="left">CIP</td>
</tr>
<tr>
<td align="left">Q</td>
<td align="left">BrS1</td>
<td align="center">
<sup>IS2-S3</sup>A<sup>185</sup>T</td>
<td align="left">BrS1, LQT3, A</td>
<td align="left">CIP</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="center">V</td>
<td align="left">BrS1, A</td>
<td align="left">VUS</td>
</tr>
<tr>
<td align="left">
<sup>IS4</sup>R<sup>219</sup>C</td>
<td align="left">A, BrS1</td>
<td align="center">
<sup>IS2</sup>E<sup>161</sup>Q</td>
<td align="left">BrS1</td>
<td align="left">NP</td>
</tr>
<tr>
<td align="left">H</td>
<td align="left">BrS1, DCM</td>
<td align="center">K</td>
<td align="left">BrS1</td>
<td align="left">CIP</td>
</tr>
<tr>
<td align="left">P</td>
<td align="left">LQT3, BrS1, More</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td rowspan="3" align="left">
<sup>IIS3</sup>E<sup>795</sup>K</td>
<td rowspan="3" align="left">BrS1</td>
<td align="center">
<sup>IIS4</sup>R<sup>808</sup>P</td>
<td align="left">LQT3</td>
<td align="left">NP</td>
</tr>
<tr>
<td align="center">C</td>
<td align="left">A</td>
<td align="left">VUS</td>
</tr>
<tr>
<td align="center">H</td>
<td align="left">LQT3, A</td>
<td align="left">VUS</td>
</tr>
<tr>
<td align="left">
<sup>IIS4-S5</sup>L<sup>825</sup>P</td>
<td align="left">BrS1</td>
<td align="center">
<sup>IIS4</sup>A<sup>819</sup>P</td>
<td align="left">BrS1</td>
<td align="left">VUS</td>
</tr>
<tr>
<td align="left">
<sup>IIS5</sup>I<sup>848</sup>F</td>
<td align="left">A, BrS1, LQT3</td>
<td align="center">
<sup>IS4</sup>V<sup>223</sup>A</td>
<td align="left">A</td>
<td align="left">LB</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="center">L</td>
<td align="left">BrS1</td>
<td align="left">NP</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="center">
<sup>IS4</sup>L<sup>227</sup>P</td>
<td align="left">BrS1</td>
<td align="left">CIP</td>
</tr>
<tr>
<td align="left">
<sup>IIIS4</sup>R<sup>1306</sup>L</td>
<td align="left">CVP</td>
<td align="center">
<sup>IIIS3</sup>I<sup>1278</sup>N</td>
<td align="left">LQT3</td>
<td align="left">NP</td>
</tr>
<tr>
<td align="left">H</td>
<td align="left">NP, BrS1</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">C</td>
<td align="left">A</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">S</td>
<td align="left">BrS1</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">
<sup>IVS2</sup>C<sup>1575</sup>Y</td>
<td align="left">A, BrS1</td>
<td align="center">
<sup>IVS3</sup>D<sup>1595</sup>H</td>
<td align="left">BrS1, LQT3, More</td>
<td align="left">LP</td>
</tr>
<tr>
<td align="left">S</td>
<td align="left">A</td>
<td align="center">N</td>
<td align="left">BrS1, More</td>
<td align="left">P</td>
</tr>
<tr>
<td rowspan="2" align="left">
<sup>IVS4-S5</sup>I<sup>1643</sup>L</td>
<td rowspan="2" align="left">NP</td>
<td align="center">
<sup>IS5</sup>D<sup>252</sup>V</td>
<td align="left">BrS1</td>
<td align="left">VUS</td>
</tr>
<tr>
<td align="center">
<sup>IVS3</sup>I<sup>1637</sup>T</td>
<td align="left">NS</td>
<td align="left">VUS</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="Tfn9">
<label>a</label>
<p>Contacts in the cryo-EM structure are shown in <xref ref-type="table" rid="T4">Table&#x20;4</xref>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>VSD-I in the activated-state structure and resting-state model. <bold>(A,B)</bold> Intra-membrane views at VSD-I in the activated <bold>(A)</bold> and resting <bold>(B)</bold> states. Side chains of some w54 residues and their contacts are indicated with green and red labels, respectively. Dashed lines indicate displacement of K<sup>228</sup> upon activation of VSD-I. <bold>(C)</bold> Matrix of contacts variants. To indicate contacts, which may switch upon activation of VSD-I, each cell is labeled &#x201c;C&#x201d;, &#x201c;M&#x201d; or &#x201c;B&#x201d; depending on whether the contact is found only in the cryo-EM structure, only in the resting-state model, or both in the cryo-EM structure and the model. Overwhelming majority of PDVs and their contact variants are associated with BrS1. See section <italic>VSD-I</italic> for more details.</p>
</caption>
<graphic xlink:href="fphar-12-756415-g005.tif"/>
</fig>
<sec id="s3-5-1">
<title>VSD-I</title>
<p>
<xref ref-type="fig" rid="F5">Figure&#x20;5</xref> shows VSD-I in the activated (A) and resting (B) states with w54 residues and their contacts. Dashed lines indicate displacement of <sup>IS4</sup>K<sup>228</sup> upon transition of the voltage-sensing helix IS4 between the resting and activated states. In the activated VSD-I, R<sup>219</sup> lacks specific inter-segment contacts, while in the resting VSD-I, R<sup>219</sup> forms a salt bridge with <sup>IS2</sup>E<sup>161</sup> (<xref ref-type="fig" rid="F5">Figure&#x20;5B</xref>). BrS1-associated substitutions R<sup>19</sup>C/H/P or E<sup>161</sup>Q/K would eliminate the salt bridge, likely destabilizing the resting VSD-I. Mutation E<sup>161</sup>K, which was found in patients with the sick sinus syndrome, BrS1, or cardiac conduction disease, reduced current density and markedly impaired activation (<xref ref-type="bibr" rid="B51">Smits et&#x20;al., 2005a</xref>).</p>
<p>Variant R<sup>219</sup>H is associated with mixed arrhythmia and dilated cardiomyopathy, likely due to the proton leak current, which was observed in biophysical studies (<xref ref-type="bibr" rid="B16">Gosselin-Badaroudine et&#x20;al., 2012</xref>; <xref ref-type="bibr" rid="B34">Moreau et&#x20;al., 2018</xref>). Mutations R<sup>219</sup>P and E<sup>161</sup>K would destroy the salt ridge and destabilize the resting state, the effect apparently inconsistent with BrS1. However, the same mutations are also associated with LQT3 (<xref ref-type="fig" rid="F5">Figure&#x20;5C</xref>).</p>
<p>In the activated VSD-I, <sup>IS2</sup>R<sup>179</sup> is H-bonded with <sup>IS2-S3</sup>T<sup>187</sup> and forms a hydrophobic contact with <sup>IS1</sup>L<sup>128</sup>. Variants of these residues are associated with BrS1, indicating that respective mutations destabilize the activated VSD-I. In the resting VSD-I, R<sup>179</sup> retains the H-bond with T<sup>187</sup> and interacts with <sup>IS2-S3</sup>H<sup>184</sup> and <sup>IS2-S3</sup>F<sup>188</sup>. Substitutions R<sup>179</sup>P/Q and T<sup>187</sup>S/A/I would eliminate the contacts, thus affecting flexibility of loop IS2-S3. Contact between R<sup>179</sup> and T<sup>187</sup> is seen in both activated and resting states of VSD-I, whereas variants of these residues are associated with BrS1, implying that flexibility of loop IS2-S3 is important for activation of VSD-I.</p>
<p>In the activated VSD-I, <sup>IS3</sup>D<sup>197</sup> is salt-bridged with <sup>IS2</sup>K<sup>175</sup> and <sup>IS4</sup>K<sup>228</sup> (<xref ref-type="fig" rid="F5">Figure&#x20;5A</xref>). In the resting VSD-I, D<sup>197</sup> retains the salt bridge with <sup>IS2</sup>K<sup>175</sup> and approaches <sup>IS4</sup>K<sup>228</sup> and <sup>IS4</sup>R<sup>225</sup> (<xref ref-type="fig" rid="F5">Figure&#x20;5B</xref>). Substitutions D<sup>197</sup>G/H/T, K<sup>175</sup>N, and R<sup>225</sup>Q/W would eliminate or weaken these contacts in both states. The fact that D<sup>197</sup>G/H/T and K<sup>175</sup>N are associated with BrS1 (<xref ref-type="fig" rid="F5">Figure&#x20;5C</xref>) suggests that salt bridge D<sup>197</sup>G : K<sup>175</sup> contributes to stabilization of the activated VSD-I. Notably, most of variants in VSD-I are associated with BrS1, but four variants are associated with both BrS1 and LQT3 (<xref ref-type="fig" rid="F5">Figure&#x20;5C</xref>). The structural cause of the later ambiguity is unclear.</p>
</sec>
<sec id="s3-5-2">
<title>VSD-II</title>
<p>The matrix of contact variants in VSD-II (<xref ref-type="fig" rid="F6">Figure&#x20;6A</xref>) shows four w54 residues, including <sup>IIS5</sup>I<sup>848</sup>, which forms state-dependent interdomain contacts with four residues in helix IS4, and <sup>IIS4-S5</sup>L<sup>825</sup> that forms interdomain contact with <sup>IIS5</sup>V<sup>1340</sup>. Most residue substitutions in the interdomain contacts are associated with BrS1, but three variants are also associated with LQT3. Homozygous mutation <sup>IIIS5</sup>V<sup>1340</sup>L was found in two female patients with atrial standstill, while in three unaffected relatives the mutations was heterozygous. In a functional study, V<sup>1340</sup>L reduced the current density and impaired channel activation (<xref ref-type="bibr" rid="B54">Tan et&#x20;al., 2018</xref>). Another mutation, V<sup>1340</sup>I, did not alter biophysical characteristics at room temperature, but at 40&#xb0;C it decreased the current density, caused hyperpolarizing shift of steady-state inactivation, and accelerated recovery from the fast inactivation (<xref ref-type="bibr" rid="B44">Samani et&#x20;al., 2009</xref>).</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>VSD-II in the activated-state structure and resting-state model. <bold>(A)</bold> Matrix of contact variants, in addition to contacts within VSD-II, slows contacts IIS4-5/IIIS5 and IIS5/IS4&#x20;<bold>(B,C)</bold> VSD-II in the activated-state cryo-EM structure <bold>(B)</bold> and resting-state model <bold>(C)</bold>. Residues from set w54 and their contacts are indicated with green and red labels, respectively. <italic>VSD-II</italic> Section for more details.</p>
</caption>
<graphic xlink:href="fphar-12-756415-g006.tif"/>
</fig>
<p>The activated VSD-II is stabilized by a salt bridge <sup>IIS4</sup>R<sup>808</sup> : <sup>IIS1</sup>E<sup>737</sup>, an H-bond <sup>IIS4</sup>R<sup>811</sup> : <sup>IIS2</sup>N<sup>753</sup>, a hydrophobic contact <sup>IIS3</sup>E<sup>795</sup> : <sup>IIS4</sup>L<sup>807</sup>, and hydrophobic contacts involving <sup>IIS4</sup>F<sup>816</sup>, <sup>IIS4</sup>A<sup>819</sup> and <sup>IIS4-S5</sup>L<sup>825</sup> (<xref ref-type="fig" rid="F6">Figure&#x20;6B</xref>). The latter contacts are also seen in the resting VSD-II, but the downshift of helix IIS4 significantly rearranged contacts involving R<sup>808</sup> and R<sup>811</sup> (<xref ref-type="fig" rid="F6">Figure&#x20;6C</xref>). Salt bridges R<sup>808</sup> : E<sup>737</sup>, R<sup>811</sup> : E<sup>795</sup> and an H-bond R<sup>808</sup> : E<sup>795</sup> apparently stabilize the resting VSD-II. Mutations R<sup>808</sup>P/H would eliminate the salt bridges and destabilize the resting state of VSD-II stronger than its activate state in which R<sup>808</sup> forms only one salt bridge. This model-based prediction agrees with the fact that variants R<sup>808</sup>&#xa0;P/H are associated with LQT3 (<xref ref-type="fig" rid="F6">Figure&#x20;6A</xref>).</p>
</sec>
<sec id="s3-5-3">
<title>VSD-III</title>
<p>The matrix of contact variants in VSD-III shows seven PDVs and seven their contact variants (<xref ref-type="fig" rid="F7">Figure&#x20;7A</xref>). Activated VSD-III is stabilized by a salt bridge <sup>IIIS4</sup>R<sup>1306</sup> : <sup>IIIS1</sup>E<sup>1225</sup>, which is seen only in the cryo-EM structure, two salt bridges seen in both the cryo-EM structure and resting-state model (R<sup>1306</sup> : <sup>IIIS2</sup>D<sup>1243</sup> and <sup>IIIS4</sup>R<sup>1316</sup> : <sup>IIIS1</sup>E<sup>1208</sup>) and the hydrophobic contact <sup>IIIS2</sup>L<sup>1239</sup> : <sup>IIIS1</sup>A<sup>1221</sup> (<xref ref-type="fig" rid="F7">Figure&#x20;7B</xref>). Elimination of the salt bridges in these variants is usually associated with BrS1 (<xref ref-type="fig" rid="F7">Figure&#x20;7A</xref>). In the cryo-EM structure, <sup>IIS1</sup>R<sup>1195</sup> and <sup>IIS2-S3</sup>G<sup>1262</sup> are farther than 5&#xa0;&#xc5; from each other (<xref ref-type="fig" rid="F7">Figure&#x20;7B</xref>), but PDV G<sup>1262</sup>S (<xref ref-type="table" rid="T6">Table&#x20;6</xref>) may form an H-bond with R<sup>1195</sup> and decrease flexibility of linker IIS2-S3.</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>Matrices of contact variants and structures of VSD-III and VSD-VI. <bold>(A)</bold> Matrix of contact variants of VSD-III. <bold>(B,C)</bold> VSD-III in the activated-state cryo-EM structure <bold>(B)</bold> and resting-state model <bold>(C)</bold>. Residues from set w54 and their contacts are indicated with green and red labels, respectively. See section <italic>VSD-III</italic> for more detail. <bold>(D)</bold> Matrix of contact variants of VSD-IV. <bold>(E</bold>) Activated-state structure of VSD-IV. Residues from set w54 and their contacts are indicated with green and red labels, respectively. See section <italic>VSD-IV</italic> for more details.</p>
</caption>
<graphic xlink:href="fphar-12-756415-g007.tif"/>
</fig>
<table-wrap id="T6" position="float">
<label>TABLE 6</label>
<caption>
<p>PDVs whose missense contact variants in the cryo-EM structure or models are not listed in ClinVar.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th rowspan="2" align="left">&#x23;</th>
<th colspan="2" align="center">PDV</th>
<th rowspan="2" align="center">Exposure</th>
<th rowspan="2" align="center">Comment</th>
</tr>
<tr>
<th align="center">Variant<sup>a</sup>
</th>
<th align="center">Syndrome<sup>b,c</sup>
</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">1</td>
<td align="left">
<sup>IS6</sup>V<sup>396</sup>L</td>
<td align="left">BrS1<sup>1,3,4</sup>
</td>
<td rowspan="2" align="left">Lipids</td>
<td rowspan="2" align="left">Tight contacts with<sup>IS5</sup>F<sup>264</sup> <sup>IP1</sup>L<sup>365</sup> and <sup>IP1</sup>L<sup>368</sup>
</td>
</tr>
<tr>
<td align="left">2</td>
<td align="left">
<sup>IIS1</sup>L<sup>732</sup>P</td>
<td align="left">BrS1</td>
</tr>
<tr>
<td align="left">3</td>
<td align="left">
<sup>IIS1-S2</sup>L<sup>736</sup>P</td>
<td align="left">BrS1</td>
<td align="left">Extracellular</td>
<td align="left">Loop Flexibility</td>
</tr>
<tr>
<td align="left">4</td>
<td align="left">
<sup>IIS1-S2</sup>H<sup>738</sup>P</td>
<td align="left">BrS1</td>
<td align="left">Extracellular</td>
<td rowspan="4" align="left">Loop Flexibility</td>
</tr>
<tr>
<td align="left">5</td>
<td align="left">
<sup>IIS3</sup>M<sup>794</sup>T</td>
<td align="left">NP</td>
<td align="left">Lipids</td>
</tr>
<tr>
<td align="left">6</td>
<td align="left">
<sup>IIS4-S5</sup>G<sup>833</sup>R</td>
<td align="left">LQT-3,NP,A, BrS1<sup>7</sup>
</td>
<td align="left">Lipids</td>
</tr>
<tr>
<td align="left">7</td>
<td align="left">
<sup>IIS5</sup>V<sup>924</sup>F</td>
<td align="left">NP</td>
<td align="left">Lipids</td>
</tr>
<tr>
<td align="left">8</td>
<td align="left">
<sup>IIIS1</sup>R<sup>1195</sup>C</td>
<td align="left">BrS1</td>
<td align="left">Cytoplasm</td>
<td rowspan="2" align="left">R<sup>1195</sup> may reach G<sup>1262</sup>
<break/>&#x201c;</td>
</tr>
<tr>
<td align="left">9</td>
<td align="left">
<sup>IIIS1</sup>R<sup>1195</sup>H</td>
<td align="left">&#x201c;</td>
<td align="left">Cytoplasm</td>
</tr>
<tr>
<td align="left">10</td>
<td align="left">
<sup>IIIS2-S3</sup>G<sup>1262</sup>S</td>
<td align="left">BrS1, LQT-3, PFHB<sup>1,3,11,12</sup>
</td>
<td align="left">Cytoplasm</td>
<td rowspan="2" align="left">Loop flexibility</td>
</tr>
<tr>
<td align="left">11</td>
<td align="left">
<sup>IIIS6</sup>I<sup>1448</sup>L</td>
<td align="left">A, BrS1, CVP<sup>1,3,4</sup>
</td>
<td align="left">Lipids</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>
<sup>a-e</sup> See footnotes to <xref ref-type="table" rid="T1">Table&#x20;1</xref>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The resting state of VSD-III is stabilized by a hydrophobic contact of I<sup>1278</sup> with methylene groups of R<sup>1306</sup> (<xref ref-type="fig" rid="F7">Figure&#x20;7C</xref>). Variant I<sup>1278</sup>V, which was found in a Thai patient with congenital complete heart block, is considered disease-causative because this variant was not found in unaffected members of the patient&#x2019;s family (<xref ref-type="bibr" rid="B56">Thongnak et&#x20;al., 2016</xref>). Substitution I<sup>1278</sup>N would destabilize the resting state in agreement with the fact that this variant is associated with LQT3 (<xref ref-type="fig" rid="F7">Figure&#x20;7A</xref>).</p>
</sec>
<sec id="s3-5-4">
<title>VSD-IV</title>
<p>The matrix of contact variants in VSD-IV shows five PDVs and seven their contacts variants (<xref ref-type="fig" rid="F7">Figure&#x20;7D</xref>). Several contacts at the cytoplasmic half of VSD-IV stabilize the activated state (<xref ref-type="fig" rid="F7">Figure&#x20;7E</xref>); weakening or elimination of these contacts in BrS1-associated PDVs would destabilize the activated VSD-IV. In contrast, LQT3-associated mutation <sup>IVS1</sup>I<sup>1534</sup>S would stabilize the activated state due to H-bond between <sup>IVS2</sup>E<sup>1574</sup> and <sup>IVS1</sup>I<sup>1534</sup>S. In both activated and resting states of VSD-IV, <sup>IVS3</sup>F<sup>1596</sup> forms a hydrophobic contact with <sup>IVS2</sup>C<sup>1575</sup> (<xref ref-type="fig" rid="F7">Figure&#x20;7D</xref>). Variants C<sup>1575</sup>S/Y are associated with BrS1, whereas variant F<sup>1596</sup>I is associated with both BrS1 and LQT3. In functional studies, F<sup>1596</sup>I did not change peak current, but enhanced steady-state inactivation and accelerated recovery from inactivation (<xref ref-type="bibr" rid="B38">Olesen et&#x20;al., 2012</xref>; <xref ref-type="bibr" rid="B19">Hoshi et&#x20;al., 2015</xref>).</p>
</sec>
</sec>
<sec id="s3-6">
<title>Domain Distribution of PDVs and their Contact Variants</title>
<p>
<xref ref-type="table" rid="T7">Table&#x20;7</xref> shows domain distribution of PDVs, their contact variants, and clinical significance of the latter variants. In the PD, 27 WT residues with a total of 38 PDVs are engaged in contacts with 45 WT residues, which have a total of 63 missense disease variants. In the four VSDs, 17 WT residues with a total of 33 PDVs contact 39 WT residues with a total of 55 missense disease variants. While majority of PDVs and their contact variants are seen in the cryo-EM structures, models of the open/closed PD and resting VSDs revealed an additional PDV and 34 contact variants. Thus, in the considered channel states, w54 residues with 82 PDVs form contacts with 84 WT residues that have a total of 118 disease variants. Current number of PDVs exceeds the published number (<xref ref-type="bibr" rid="B55">Tarnovskaya et&#x20;al., 2020</xref>) because new variants of w54 residues were recently reported in ClinVar. For majority of the published PDVs clinical significance is still VUS/NP/CIP, but two variants, <sup>IS5</sup>L<sup>250</sup>V and <sup>IVS6</sup>M<sup>1766</sup>L, were recently reclassified as P/LP. As many as 104 contact disease variants are categorized as VUS/NP/CIP variants. Further bioinformatics analysis is required to predict potentially damaging effect of these variants, but the fact that they are coupled with earlier predicted PDVs suggests that a large portion of the 104 variants would be reclassified as a P/LP variants.</p>
<table-wrap id="T7" position="float">
<label>TABLE 7</label>
<caption>
<p>Domain distribution of PDVs and their contact variants.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th colspan="4" align="left">PDVs</th>
<th colspan="2" align="center">Contacts</th>
<th colspan="4" align="center">Clinical significance of contact variants</th>
</tr>
<tr>
<th align="left">Domain</th>
<th align="center">State</th>
<th align="center">WT</th>
<th align="center">Variants</th>
<th align="center">WT</th>
<th align="center">Variants</th>
<th align="center">VUS</th>
<th align="center">P/LP</th>
<th align="center">NP</th>
<th align="center">CIP</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="3" align="left">PD</td>
<td align="left">Inactivated<xref ref-type="table-fn" rid="Tfn10">
<sup>a</sup>
</xref>
</td>
<td rowspan="3" align="center">27</td>
<td rowspan="3" align="center">38</td>
<td align="center">37</td>
<td align="center">49</td>
<td align="center">29</td>
<td align="center">7</td>
<td align="center">11</td>
<td align="center">2</td>
</tr>
<tr>
<td align="left">Open<xref ref-type="table-fn" rid="Tfn11">
<sup>b</sup>
</xref>
</td>
<td align="center">3</td>
<td align="center">5</td>
<td align="center">2</td>
<td align="center">2</td>
<td align="center">1</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Closed<xref ref-type="table-fn" rid="Tfn11">
<sup>b</sup>
</xref>
</td>
<td align="center">5</td>
<td align="center">9</td>
<td align="center">2</td>
<td align="center">1</td>
<td align="center">5</td>
<td align="center">1</td>
</tr>
<tr>
<td rowspan="2" align="left">VSD-I</td>
<td align="left">Activated<xref ref-type="table-fn" rid="Tfn10">
<sup>a</sup>
</xref>
</td>
<td align="center">5</td>
<td align="center">13</td>
<td align="center">11</td>
<td align="center">15</td>
<td align="center">8</td>
<td rowspan="6" align="center">1</td>
<td align="center">2</td>
<td align="center">4</td>
</tr>
<tr>
<td align="left">Resting<xref ref-type="table-fn" rid="Tfn12">
<sup>c</sup>
</xref>
</td>
<td align="center">1</td>
<td align="center">3</td>
<td align="center">3</td>
<td align="center">6</td>
<td align="center">2</td>
<td rowspan="2" align="center">2</td>
<td align="center">2</td>
</tr>
<tr>
<td rowspan="2" align="left">VSD-II</td>
<td align="left">Activated<xref ref-type="table-fn" rid="Tfn10">
<sup>a</sup>
</xref>
</td>
<td rowspan="2" align="center">4</td>
<td rowspan="2" align="center">5</td>
<td align="center">8</td>
<td align="center">10</td>
<td align="center">8</td>
<td align="center">2</td>
</tr>
<tr>
<td align="left">Resting<xref ref-type="table-fn" rid="Tfn12">
<sup>c</sup>
</xref>
</td>
<td align="center">6</td>
<td align="center">10</td>
<td align="center">6</td>
<td align="center">2</td>
<td align="center">2</td>
</tr>
<tr>
<td rowspan="2" align="left">VSD-III</td>
<td align="left">Activated<xref ref-type="table-fn" rid="Tfn10">
<sup>a</sup>
</xref>
</td>
<td rowspan="2" align="center">3</td>
<td rowspan="2" align="center">7</td>
<td align="center">4</td>
<td align="center">6</td>
<td rowspan="2" align="center">4</td>
<td align="center">1</td>
<td rowspan="5" align="center">1</td>
</tr>
<tr>
<td align="left">Resting<xref ref-type="table-fn" rid="Tfn12">
<sup>c</sup>
</xref>
</td>
<td align="center">1</td>
<td align="center">1</td>
<td rowspan="4" align="center">1</td>
</tr>
<tr>
<td rowspan="2" align="left">VSD-IV<xref ref-type="table-fn" rid="Tfn13">
<sup>d</sup>
</xref>
</td>
<td align="left">Activated<xref ref-type="table-fn" rid="Tfn10">
<sup>a</sup>
</xref>
</td>
<td rowspan="2" align="center">4</td>
<td rowspan="2" align="center">5</td>
<td align="center">4</td>
<td align="center">4</td>
<td align="center">3</td>
<td align="center">1</td>
</tr>
<tr>
<td align="left">Resting<xref ref-type="table-fn" rid="Tfn12">
<sup>c</sup>
</xref>
</td>
<td rowspan="2" align="center">2</td>
<td align="center">3</td>
<td rowspan="2" align="center">1</td>
<td rowspan="2" align="center">2</td>
</tr>
<tr>
<td rowspan="2" align="left">Total</td>
<td rowspan="3" align="left"/>
<td align="center">10</td>
<td align="center">11</td>
<td align="left"/>
</tr>
<tr>
<td align="center">54</td>
<td align="center">82</td>
<td align="center">84</td>
<td align="center">118</td>
<td rowspan="2" align="center">65</td>
<td rowspan="2" align="center">14</td>
<td rowspan="2" align="center">25</td>
<td rowspan="2" align="center">14</td>
</tr>
<tr>
<td align="left">Set<xref ref-type="table-fn" rid="Tfn14">
<sup>e</sup>
</xref>
</td>
<td align="center">
<bold>w54</bold>
</td>
<td align="center">
<bold>PDV</bold>
</td>
<td align="center">
<bold>c84</bold>
</td>
<td align="center">
<bold>cv118</bold>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="Tfn10">
<label>a</label>
<p>Cryo-EM structure.</p>
</fn>
<fn id="Tfn11">
<label>b</label>
<p>WT residues that have contacts variants in the inactivated PD (cryo-EM structure) are not counted.</p>
</fn>
<fn id="Tfn12">
<label>c</label>
<p>WT residues that have contacts variants in the activated VSD (cryo-EM structure) are not counted.</p>
</fn>
<fn id="Tfn13">
<label>d</label>
<p>Location is not shown for WT residues that do not form contacts with disease-associated residues.</p>
</fn>
<fn id="Tfn14">
<label>e</label>
<p>Names of the sets are shown in bold.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>
<xref ref-type="table" rid="T8">Table&#x20;8</xref> shows domain distribution of disease variants. Most of these are associated with BrS1, followed by LQT3 and unspecified arrhythmia. A total of 32 variants are associated with other diseases, which are specified in <xref ref-type="table" rid="T1">Tables 1</xref>&#x2013;<xref ref-type="table" rid="T5">5</xref>. In the contact variant matrices respective variants are not colored. It should be noted that most of &#x201c;other&#x201d; diseases are associated with the Nav1.5 loss-of-function. The cases when variants associated with &#x201c;other&#x201d; loss-of function diseases are coupled with BrS1-associated variants provide additional examples of contacts in which mutation of either partner destabilizes the open channel.</p>
<table-wrap id="T8" position="float">
<label>TABLE 8</label>
<caption>
<p>Domain distribution of disease variants.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th rowspan="2" align="left">Location</th>
<th rowspan="2" align="center">State</th>
<th colspan="2" align="center">BrS1</th>
<th colspan="2" align="center">LQT3</th>
<th colspan="2" align="center">Arrythmias</th>
<th colspan="2" align="center">Other diseases</th>
</tr>
<tr>
<th align="center">PDV</th>
<th align="center">Contacts</th>
<th align="center">PDV</th>
<th align="center">Contacts</th>
<th align="center">PDV</th>
<th align="center">Contacts</th>
<th align="center">PDV</th>
<th align="center">Contacts</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="3" align="left">PD</td>
<td align="left">Inactivated <xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td rowspan="3" align="center">21</td>
<td align="center">30</td>
<td rowspan="4" align="center">6</td>
<td align="center">10</td>
<td rowspan="7" align="center">3</td>
<td rowspan="4" align="center">6</td>
<td rowspan="3" align="center">10</td>
<td align="center">7</td>
</tr>
<tr>
<td align="left">Open <xref ref-type="table-fn" rid="Tfn1">
<sup>b</sup>
</xref>
</td>
<td align="center">2</td>
<td align="center">3</td>
<td align="center">1</td>
</tr>
<tr>
<td align="left">Closed <xref ref-type="table-fn" rid="Tfn1">
<sup>b</sup>
</xref>
</td>
<td align="center">6</td>
<td align="center">3</td>
<td align="center">1</td>
</tr>
<tr>
<td rowspan="2" align="left">VSD1</td>
<td align="left">Activated <xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td align="center">10</td>
<td align="center">14</td>
<td align="center">2</td>
<td rowspan="2" align="center">3</td>
<td rowspan="2" align="center">2</td>
</tr>
<tr>
<td align="left">Resting <xref ref-type="table-fn" rid="Tfn1">
<sup>c</sup>
</xref>
</td>
<td align="center">3</td>
<td align="center">5</td>
<td align="center">1</td>
<td align="center">2</td>
<td align="center">1</td>
</tr>
<tr>
<td rowspan="2" align="left">VSD2</td>
<td align="left">Activated <xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td rowspan="2" align="center">3</td>
<td align="center">7</td>
<td rowspan="6" align="center">1</td>
<td align="center">3</td>
<td align="center">1</td>
<td rowspan="2" align="center">2</td>
<td align="center">1</td>
</tr>
<tr>
<td align="left">Resting <xref ref-type="table-fn" rid="Tfn1">
<sup>c</sup>
</xref>
</td>
<td align="center">4</td>
<td align="center">2</td>
<td align="center">2</td>
<td rowspan="3" align="center">2</td>
</tr>
<tr>
<td rowspan="2" align="left">VSD3</td>
<td align="left">Activated <xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td rowspan="2" align="center">5</td>
<td rowspan="2" align="center">5</td>
<td align="center">1</td>
<td rowspan="4" align="center">1</td>
<td rowspan="4" align="center">1</td>
<td rowspan="2" align="center">1</td>
</tr>
<tr>
<td align="left">Resting <xref ref-type="table-fn" rid="Tfn1">
<sup>c</sup>
</xref>
</td>
<td align="center">1</td>
</tr>
<tr>
<td rowspan="2" align="left">VSD4</td>
<td align="left">Activated <xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td rowspan="2" align="center">4</td>
<td align="center">2</td>
<td align="center">2</td>
<td rowspan="2" align="center">1</td>
<td rowspan="2" align="center">1</td>
</tr>
<tr>
<td align="left">Resting <xref ref-type="table-fn" rid="Tfn1">
<sup>c</sup>
</xref>
</td>
<td align="center">3</td>
<td align="center">1</td>
</tr>
<tr>
<td align="left">Total</td>
<td align="left"/>
<td align="center">46</td>
<td align="center">78</td>
<td align="center">8</td>
<td align="center">30</td>
<td align="center">4</td>
<td align="center">11</td>
<td align="center">17</td>
<td align="center">15</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>
<sup>a-c</sup> See footnotes to <xref ref-type="table" rid="T7">Table&#x20;7</xref>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Only eleven of 82 PDVs (13%) are not coupled with other disease variants (<xref ref-type="table" rid="T6">Table&#x20;6</xref>). One PDV (<sup>IS6</sup>V<sup>396</sup>L) is involved in tight intra-PD contacts, while 10 PDVs are exposed to lipids, cytoplasm or extracellular space. Three variants (<sup>IIS1-S2</sup>L<sup>736</sup>P, <sup>IIS1-S2</sup>H<sup>738</sup>P, and <sup>IIIS2-S3</sup>G<sup>1262</sup>S) affect flexibility of VSD linkers. The fact that 87% of PDVs are coupled with disease variants supports bioinformatics-based predictions of PDVs (<xref ref-type="bibr" rid="B55">Tarnovskaya et&#x20;al., 2020</xref>) and suggests that many contact variants of PDVs, which are currently annotated as VUS/NP/CIP, may be reclassified as P/LP variants.</p>
</sec>
<sec id="s3-7">
<title>Limitations of the Approach</title>
<p>In the absence of cryo-EM structures of the hNav1.5 channel with the open and closed pore domain and resting VSDs, we modeled these states using as templates crystal structures of prokaryotic sodium channel NavAb (see Methods). Some of the proposed intersegment contacts in these states require future validation in functional studies. Ionizable residues in VSDs are involved in multiple state-dependent electrostatic interactions. Structural interpretation of respective mutations may be ambiguous.</p>
</sec>
</sec>
<sec id="s4">
<title>Concluding Remarks</title>
<p>Only a small fraction of known missense variants of the hNav1.5 channel are classified as P/LP variants. Prediction of damaging effects of VUS/NP/CIP variants would improve diagnostics of increasingly large number of genotyped cardiac patients. Here we employed a recent cryo-EM structure of the Nav1.5 channels and <italic>ad-hoc</italic> homology models of the channel with the open or closed PD and resting VSDs to explore intersegment contacts of 54 WT&#x20;residues whose VUS/NP/CIP variants are reclassified as PDVs (<xref ref-type="bibr" rid="B55">Tarnovskaya et&#x20;al., 2020</xref>). We found that 44 of the 54 WT residues form intersegment contacts with 84 WT residues for&#x20;which 118 disease variants are reported. Overwhelming majority of the contact variants is categorized as VUS/NP/CIP. We propose that if two WT residues, which are engaged in an intersegment contact, have VUS/NP/CIP variants, these are P/LP variants. Validation of this proposition requires bioinformatics analysis of a large set of contacts involving disease variants and electrophysiological testing of some contacts (<xref ref-type="bibr" rid="B50">Smith and Goldin, 1997</xref>; <xref ref-type="bibr" rid="B2">B&#xe9;nitah et&#x20;al., 1999</xref>). In many contacts, variants of either residue are associated with the same syndrome likely because they similarly affect stability of a particular channel state. To facilitate recognition of such coupled variants, we presented them in colored matrices. Structural analysis suggested atomic mechanism of the channel dysfunction in scores of coupled variants. These include BrS1-associated mutations in P-loops that would destabilize the selectivity-filter slow inactivation gate, BrS1-associated variants in VSDs that would destabilize their activated states, and LQT3-associated mutations in PD that would stabilize the channel states with the open pore (or destabilize states with the closed pore). Understanding these mechanisms may assist structure-based predictions of pathogenic variants and contribute to general physiology of ion channels.</p>
</sec>
</body>
<back>
<sec id="s5">
<title>Author Contributions</title>
<p>VK, Molecular modeling, manuscript writing; AZ, Collecting literature on channelopathies, manuscript writing; AK, Project administration, manuscript editing; BZ, Conceptualization, supervising, manuscript writing and editing, funding acquisition.</p>
</sec>
<sec id="s6">
<title>Funding</title>
<p>This study was supported by grants to BSZ from the Natural Sciences and Engineering Research Council of Canada (RGPIN-2020-07100) and Russian Science Foundation (17-15-01292-&#x03A0;).</p>
</sec>
<sec sec-type="COI-statement" id="s7">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s8">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, orclaim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ack>
<p>Computations were performed using facilities of Compute Canada (<ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.computeca">www.computeca</ext-link>).</p>
</ack>
<sec id="s9">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2021.756415/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fphar.2021.756415/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.ZIP" id="SM1" mimetype="application/ZIP" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<sec id="s10">
<title>Abbreviations</title>
<p>BrS1, brugada syndrome type 1; CIP, conflicting interpretations of pathogenicity; LQT3, long QT syndrome type 3; MC, monte carlo; MCM, MC-minimizations; NP, data on pathogenicity are not provided; P1 and P2, membrane-descending and membrane-ascending pore helices in P-loops; PD, pore domain; P/LP, pathogenic/likely pathogenic; PDV,&#x20;potentially damaging variant (P/LP and PDV are used, respectively, for database-listed variants and those predicted computationally); SF, selectivity filter; TM, transmembrane; VSD, voltage-sensing domain; VUS, variant of uncertain clinical significance; w54, 54 wild-type residues for which PDVs are predicted; WT, wild&#x20;type.</p>
</sec>
<ref-list>
<title>Reference</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amin</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Asghari-Roodsari</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>H. L.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Cardiac Sodium Channelopathies</article-title>. <source>Pflugers Arch.</source> <volume>460</volume> (<issue>2</issue>), <fpage>223</fpage>&#x2013;<lpage>237</lpage>. <pub-id pub-id-type="doi">10.1007/s00424-009-0761-0</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>B&#xe9;nitah</surname>
<given-names>J.&#x20;P.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Balser</surname>
<given-names>J.&#x20;R.</given-names>
</name>
<name>
<surname>Tomaselli</surname>
<given-names>G. F.</given-names>
</name>
<name>
<surname>Marb&#xe1;n</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Molecular Dynamics of the Sodium Channel Pore Vary with Gating: Interactions between P-Segment Motions and Inactivation</article-title>. <source>J.&#x20;Neurosci.</source> <volume>19</volume> (<issue>5</issue>), <fpage>1577</fpage>&#x2013;<lpage>1585</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.19-05-01577.1999</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bodian</surname>
<given-names>D. L.</given-names>
</name>
<name>
<surname>Vilboux</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hourigan</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Jenevein</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Mani</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kent</surname>
<given-names>K. C.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Genomic Analysis of an Infant with Intractable Diarrhea and Dilated Cardiomyopathy</article-title>. <source>Cold Spring Harb Mol. Case Stud.</source> <volume>3</volume> (<issue>6</issue>), <fpage>a002055</fpage>. <pub-id pub-id-type="doi">10.1101/mcs.a002055</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brewer</surname>
<given-names>K. R.</given-names>
</name>
<name>
<surname>Kuenze</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Vanoye</surname>
<given-names>C. G.</given-names>
</name>
<name>
<surname>George</surname>
<given-names>A. L.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Meiler</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>C. R.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Structures Illuminate Cardiac Ion Channel Functions in Health and in Long QT Syndrome</article-title>. <source>Front. Pharmacol.</source> <volume>11</volume>, <fpage>550</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2020.00550</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brooks</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Pettitt</surname>
<given-names>B. M.</given-names>
</name>
<name>
<surname>Karplus</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>1985</year>). <article-title>Structural and Energetic Effects of Truncating Long Ranged Interactions in Ionic and Polar Fluids</article-title>. <source>J.&#x20;Chem. Phys.</source> <volume>83</volume>, <fpage>5897</fpage>&#x2013;<lpage>5908</lpage>. <pub-id pub-id-type="doi">10.1063/1.449621</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bruhova</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Zhorov</surname>
<given-names>B. S.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>A Homology Model of the Pore Domain of a Voltage-Gated Calcium Channel Is Consistent with Available SCAM Data</article-title>. <source>J.&#x20;Gen. Physiol.</source> <volume>135</volume> (<issue>3</issue>), <fpage>261</fpage>&#x2013;<lpage>274</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.200910288</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Butterfield</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>P. R.</given-names>
</name>
<name>
<surname>Waters</surname>
<given-names>M. L.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Contribution of Aromatic Interactions to Alpha-helix Stability</article-title>. <source>J.&#x20;Am. Chem. Soc.</source> <volume>124</volume> (<issue>33</issue>), <fpage>9751</fpage>&#x2013;<lpage>9755</lpage>. <pub-id pub-id-type="doi">10.1021/ja026668q</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calloe</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Refaat</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Grubb</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wojciak</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Campagna</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Thomsen</surname>
<given-names>N. M.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Characterization and Mechanisms of Action of Novel NaV1.5 Channel Mutations Associated with Brugada Syndrome</article-title>. <source>Circ. Arrhythm Electrophysiol.</source> <volume>6</volume> (<issue>1</issue>), <fpage>177</fpage>&#x2013;<lpage>184</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCEP.112.974220</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carboni</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z. S.</given-names>
</name>
<name>
<surname>Neplioueva</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Starmer</surname>
<given-names>C. F.</given-names>
</name>
<name>
<surname>Grant</surname>
<given-names>A. O.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Slow Sodium Channel Inactivation and Use-dependent Block Modulated by the Same Domain IV S6 Residue</article-title>. <source>J.&#x20;Membr. Biol.</source> <volume>207</volume> (<issue>2</issue>), <fpage>107</fpage>&#x2013;<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1007/s00232-005-0805-0</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chatterjee</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Vyas</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Chalamalasetti</surname>
<given-names>S. V.</given-names>
</name>
<name>
<surname>Sahu</surname>
<given-names>I. D.</given-names>
</name>
<name>
<surname>Clatot</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>The Voltage-Gated Sodium Channel Pore Exhibits Conformational Flexibility during Slow Inactivation</article-title>. <source>J.&#x20;Gen. Physiol.</source> <volume>150</volume> (<issue>9</issue>), <fpage>1333</fpage>&#x2013;<lpage>1347</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.201812118</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coppola</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Corrado</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Curnis</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Maglia</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Oriente</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mignano</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Update on Brugada Syndrome 2019</article-title>. <source>Curr. Probl. Cardiol.</source> <volume>46</volume>, <fpage>100454</fpage>. <pub-id pub-id-type="doi">10.1016/j.cpcardiol.2019.100454</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cordeiro</surname>
<given-names>J.&#x20;M.</given-names>
</name>
<name>
<surname>Barajas-Martinez</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Burashnikov</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Pfeiffer</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Orsino</surname>
<given-names>A. M.</given-names>
</name>
<etal/>
</person-group> (<year>2006</year>). <article-title>Compound Heterozygous Mutations P336L and I1660V in the Human Cardiac Sodium Channel Associated with the Brugada Syndrome</article-title>. <source>Circulation</source> <volume>114</volume> (<issue>19</issue>), <fpage>2026</fpage>&#x2013;<lpage>2033</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.106.627489</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>F. X.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J.&#x20;G.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>G. H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S. Y.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>C. L.</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>Relationship between Congenital Long QT Syndrome and Brugada Syndrome Gene Mutation</article-title>. <source>Zhongguo Yi Xue Ke Xue Yuan Xue Bao</source> <volume>27</volume> (<issue>3</issue>), <fpage>289</fpage>&#x2013;<lpage>294</lpage>. </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tikhonov</surname>
<given-names>D. B.</given-names>
</name>
<name>
<surname>Nomura</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zhorov</surname>
<given-names>B. S.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Mutational Analysis of State-dependent Contacts in the Pore Module of Eukaryotic Sodium Channels</article-title>. <source>Arch. Biochem. Biophys.</source> <volume>652</volume>, <fpage>59</fpage>&#x2013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/j.abb.2018.06.008</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garden</surname>
<given-names>D. P.</given-names>
</name>
<name>
<surname>Zhorov</surname>
<given-names>B. S.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Docking Flexible Ligands in Proteins with a Solvent Exposure- and Distance-dependent Dielectric Function</article-title>. <source>J.&#x20;Comput. Aided Mol. Des.</source> <volume>24</volume> (<issue>2</issue>), <fpage>91</fpage>&#x2013;<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1007/s10822-009-9317-9</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gosselin-Badaroudine</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Keller</surname>
<given-names>D. I.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Pouliot</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Chatelier</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Osswald</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>A Proton Leak Current through the Cardiac Sodium Channel Is Linked to Mixed Arrhythmia and the Dilated Cardiomyopathy Phenotype</article-title>. <source>PLoS One</source> <volume>7</volume> (<issue>5</issue>), <fpage>e38331</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0038331</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Groenewegen</surname>
<given-names>W. A.</given-names>
</name>
<name>
<surname>Bezzina</surname>
<given-names>C. R.</given-names>
</name>
<name>
<surname>van Tintelen</surname>
<given-names>J.&#x20;P.</given-names>
</name>
<name>
<surname>Hoorntje</surname>
<given-names>T. M.</given-names>
</name>
<name>
<surname>Mannens</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Wilde</surname>
<given-names>A. A.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>A Novel LQT3 Mutation Implicates the Human Cardiac Sodium Channel Domain IVS6 in Inactivation Kinetics</article-title>. <source>Cardiovasc. Res.</source> <volume>57</volume> (<issue>4</issue>), <fpage>1072</fpage>&#x2013;<lpage>1078</lpage>. <pub-id pub-id-type="doi">10.1016/s0008-6363(02)00838-6</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hirose</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Makiyama</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Melgari</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wuriyanghai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yokoi</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Propranolol Attenuates Late Sodium Current in a Long QT Syndrome Type 3-Human Induced Pluripotent Stem Cell Model</article-title>. <source>Front Cel Dev Biol</source>. <volume>8</volume>, <fpage>761</fpage>. <pub-id pub-id-type="doi">10.3389/fcell.2020.00761</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoshi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kaufman</surname>
<given-names>E. S.</given-names>
</name>
<name>
<surname>Desch&#xea;nes</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Polygenic Case of Long QT Syndrome Confirmed through Functional Characterization Informs the Interpretation of Genetic Screening Results</article-title>. <source>Heartrhythm Case Rep.</source> <volume>1</volume> (<issue>4</issue>), <fpage>201</fpage>&#x2013;<lpage>205</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrcr.2015.02.011</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>S. F.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Structure-based Assessment of Disease-Related Mutations in Human Voltage-Gated Sodium Channels</article-title>. <source>Protein Cell</source> <volume>8</volume> (<issue>6</issue>), <fpage>401</fpage>&#x2013;<lpage>438</lpage>. <pub-id pub-id-type="doi">10.1007/s13238-017-0372-z</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaltman</surname>
<given-names>J.&#x20;R.</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>Y. P.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Re-evaluating Pathogenicity of Variants Associated with the Long QT Syndrome</article-title>. <source>J.&#x20;Cardiovasc. Electrophysiol.</source> <volume>29</volume> (<issue>1</issue>), <fpage>98</fpage>&#x2013;<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1111/jce.13355</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kapplinger</surname>
<given-names>J.&#x20;D.</given-names>
</name>
<name>
<surname>Giudicessi</surname>
<given-names>J.&#x20;R.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Tester</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Callis</surname>
<given-names>T. E.</given-names>
</name>
<name>
<surname>Valdivia</surname>
<given-names>C. R.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Enhanced Classification of Brugada Syndrome-Associated and Long-QT Syndrome-Associated Genetic Variants in the SCN5A-Encoded Na(v)1.5 Cardiac Sodium Channel</article-title>. <source>Circ. Cardiovasc. Genet.</source> <volume>8</volume> (<issue>4</issue>), <fpage>582</fpage>&#x2013;<lpage>595</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCGENETICS.114.000831</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kapplinger</surname>
<given-names>J.&#x20;D.</given-names>
</name>
<name>
<surname>Tester</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Alders</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Benito</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Berthet</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Brugada</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>An International Compendium of Mutations in the SCN5A-Encoded Cardiac Sodium Channel in Patients Referred for Brugada Syndrome Genetic Testing</article-title>. <source>Heart Rhythm</source> <volume>7</volume> (<issue>1</issue>), <fpage>33</fpage>&#x2013;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2009.09.069</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kato</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Makiyama</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>W. G.</given-names>
</name>
<name>
<surname>Kimura</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Naiki</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Cardiac Channelopathies Associated with Infantile Fatal Ventricular Arrhythmias: from the Cradle to the Bench</article-title>. <source>J.&#x20;Cardiovasc. Electrophysiol.</source> <volume>25</volume> (<issue>1</issue>), <fpage>66</fpage>&#x2013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1111/jce.12270</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Korkosh</surname>
<given-names>V. S.</given-names>
</name>
<name>
<surname>Kiselev</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Mikhaylov</surname>
<given-names>E. N.</given-names>
</name>
<name>
<surname>Kostareva</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Zhorov</surname>
<given-names>B. S.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Atomic Mechanisms of Timothy Syndrome-Associated Mutations in Calcium Channel Cav1.2</article-title>. <source>Front. Physiol.</source> <volume>10</volume>, <fpage>335</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2019.00335</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Korkosh</surname>
<given-names>V. S.</given-names>
</name>
<name>
<surname>Zhorov</surname>
<given-names>B. S.</given-names>
</name>
<name>
<surname>Tikhonov</surname>
<given-names>D. B.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Folding Similarity of the Outer Pore Region in Prokaryotic and Eukaryotic Sodium Channels Revealed by Docking of Conotoxins GIIIA, PIIIA, and KIIIA in a NavAb-Based Model of Nav1.4</article-title>. <source>J.&#x20;Gen. Physiol.</source> <volume>144</volume> (<issue>3</issue>), <fpage>231</fpage>&#x2013;<lpage>244</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.201411226</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Landrum</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.&#x20;M.</given-names>
</name>
<name>
<surname>Benson</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Chao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chitipiralla</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>ClinVar: Public Archive of Interpretations of Clinically Relevant Variants</article-title>. <source>Nucleic Acids Res.</source> <volume>44</volume> (<issue>D1</issue>), <fpage>D862</fpage>&#x2013;<lpage>D868</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkv1222</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lenaeus</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Gamal El-Din</surname>
<given-names>T. M.</given-names>
</name>
<name>
<surname>Ing</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ramanadane</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Pom&#xe8;s</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Structures of Closed and Open States of a Voltage-Gated Sodium Channel</article-title>. <source>Proc. Natl. Acad. Sci. U S A.</source> <volume>114</volume> (<issue>15</issue>), <fpage>E3051</fpage>&#x2013;<lpage>E3060</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1700761114</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>SCN5A Variants: Association with Cardiac Disorders</article-title>. <source>Front. Physiol.</source> <volume>9</volume>, <fpage>1372</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2018.01372</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Structural Basis for Pore Blockade of the Human Cardiac Sodium Channel Nav 1.5 by the Antiarrhythmic Drug Quinidine&#x2a;</article-title>. <source>Angew. Chem. Int. Ed. Engl.</source> <volume>60</volume> (<issue>20</issue>), <fpage>11474</fpage>&#x2013;<lpage>11480</lpage>. <pub-id pub-id-type="doi">10.1002/anie.202102196</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Scheraga</surname>
<given-names>H. A.</given-names>
</name>
</person-group> (<year>1987</year>). <article-title>Monte Carlo-Minimization Approach to the Multiple-Minima Problem in Protein Folding</article-title>. <source>Proc. Natl. Acad. Sci. U S A.</source> <volume>84</volume> (<issue>19</issue>), <fpage>6611</fpage>&#x2013;<lpage>6615</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.84.19.6611</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Sallam</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Itzhaki</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Garg</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome</article-title>. <source>J.&#x20;Am. Coll. Cardiol.</source> <volume>68</volume> (<issue>19</issue>), <fpage>2086</fpage>&#x2013;<lpage>2096</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2016.07.779</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Long</surname>
<given-names>S. B.</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>E. B.</given-names>
</name>
<name>
<surname>MacKinnon</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Atomic Structure of a Voltage-dependent K&#x2b; Channel in a Lipid Membrane-like Environment</article-title>. <source>Nature</source> <volume>450</volume> (<issue>7168</issue>), <fpage>376</fpage>&#x2013;<lpage>382</lpage>. <pub-id pub-id-type="doi">10.1038/nature06265</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moreau</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gosselin-Badaroudine</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mercier</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Burger</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Keller</surname>
<given-names>D. I.</given-names>
</name>
<name>
<surname>Chahine</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>A Leaky Voltage Sensor Domain of Cardiac Sodium Channels Causes Arrhythmias Associated with Dilated Cardiomyopathy</article-title>. <source>Sci. Rep.</source> <volume>8</volume> (<issue>1</issue>), <fpage>13804</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-018-31772-0</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mottaz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>David</surname>
<given-names>F. P.</given-names>
</name>
<name>
<surname>Veuthey</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Yip</surname>
<given-names>Y. L.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Easy Retrieval of Single Amino-Acid Polymorphisms and Phenotype Information Using SwissVar</article-title>. <source>Bioinformatics</source> <volume>26</volume> (<issue>6</issue>), <fpage>851</fpage>&#x2013;<lpage>852</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btq028</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>N&#xfa;&#xf1;ez</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Barana</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Amor&#xf3;s</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>de la Fuente</surname>
<given-names>M. G.</given-names>
</name>
<name>
<surname>Dolz-Gait&#xf3;n</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>G&#xf3;mez</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>p.D1690N Nav1.5 Rescues p.G1748D Mutation Gating Defects in a Compound Heterozygous Brugada Syndrome Patient</article-title>. <source>Heart Rhythm</source> <volume>10</volume> (<issue>2</issue>), <fpage>264</fpage>&#x2013;<lpage>272</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2012.10.025</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O&#x27;Leary</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Chahine</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>MTSET Modification of D4S6 Cysteines Stabilize the Fast Inactivated State of Nav1.5 Sodium Channels</article-title>. <source>Front. Pharmacol.</source> <volume>6</volume>, <fpage>118</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2015.00118</pub-id> </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olesen</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Holst</surname>
<given-names>A. G.</given-names>
</name>
<name>
<surname>Nielsen</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Nielsen</surname>
<given-names>J.&#x20;B.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>High Prevalence of Long QT Syndrome-Associated SCN5A Variants in Patients with Early-Onset Lone Atrial Fibrillation</article-title>. <source>Circ. Cardiovasc. Genet.</source> <volume>5</volume> (<issue>4</issue>), <fpage>450</fpage>&#x2013;<lpage>459</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCGENETICS.111.962597</pub-id> </citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ortiz-Bonnin</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Rinn&#xe9;</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Moss</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Streit</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Scharf</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Richter</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Electrophysiological Characterization of a Large Set of Novel Variants in the SCN5A-Gene: Identification of Novel LQTS3 and BrS Mutations</article-title>. <source>Pflugers Arch.</source> <volume>468</volume> (<issue>8</issue>), <fpage>1375</fpage>&#x2013;<lpage>1387</lpage>. <pub-id pub-id-type="doi">10.1007/s00424-016-1844-3</pub-id> </citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Priganc</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zigov&#xe1;</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Boro&#x148;ov&#xe1;</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Bernasovsk&#xe1;</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Doj&#x10d;&#xe1;kov&#xe1;</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Szabadosov&#xe1;</surname>
<given-names>V.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Analysis of SCN5A Gene Variants in East Slovak Patients with Cardiomyopathy</article-title>. <source>J.&#x20;Clin. Lab. Anal.</source> <volume>31</volume> (<issue>2</issue>), <fpage>e22037</fpage>. <pub-id pub-id-type="doi">10.1002/jcla.22037</pub-id> </citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richards</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Aziz</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Bale</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bick</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gastier-Foster</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Standards and Guidelines for the Interpretation of Sequence Variants: a Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology</article-title>. <source>Genet. Med.</source> <volume>17</volume> (<issue>5</issue>), <fpage>405</fpage>&#x2013;<lpage>424</lpage>. <pub-id pub-id-type="doi">10.1038/gim.2015.30</pub-id> </citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rivolta</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Clancy</surname>
<given-names>C. E.</given-names>
</name>
<name>
<surname>Tateyama</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Priori</surname>
<given-names>S. G.</given-names>
</name>
<name>
<surname>Kass</surname>
<given-names>R. S.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>A Novel SCN5A Mutation Associated with Long QT-3: Altered Inactivation Kinetics and Channel Dysfunction</article-title>. <source>Physiol. Genomics</source> <volume>10</volume> (<issue>3</issue>), <fpage>191</fpage>&#x2013;<lpage>197</lpage>. <pub-id pub-id-type="doi">10.1152/physiolgenomics.00039.2002</pub-id> </citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rudic</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Chaykovskaya</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tsyganov</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kalinin</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>T&#xfc;l&#xfc;men</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Papavassiliu</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Simultaneous Non-invasive Epicardial and Endocardial Mapping in Patients with Brugada Syndrome: New Insights into Arrhythmia Mechanisms</article-title>. <source>J.&#x20;Am. Heart Assoc.</source> <volume>5</volume> (<issue>11</issue>), <fpage>e004095</fpage>. <pub-id pub-id-type="doi">10.1161/JAHA.116.004095</pub-id> </citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Samani</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ai</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Shuraih</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mathuria</surname>
<given-names>N. S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>A Novel SCN5A Mutation V1340I in Brugada Syndrome Augmenting Arrhythmias during Febrile Illness</article-title>. <source>Heart Rhythm</source> <volume>6</volume> (<issue>9</issue>), <fpage>1318</fpage>&#x2013;<lpage>1326</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrthm.2009.05.016</pub-id> </citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Savio-Galimberti</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Argenziano</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Antzelevitch</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Cardiac Arrhythmias Related to Sodium Channel Dysfunction</article-title>. <source>Handb Exp. Pharmacol.</source> <volume>246</volume>, <fpage>331</fpage>&#x2013;<lpage>354</lpage>. <pub-id pub-id-type="doi">10.1007/164_2017_43</pub-id> </citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwartz</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Priori</surname>
<given-names>S. G.</given-names>
</name>
<name>
<surname>Dumaine</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Napolitano</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Antzelevitch</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Stramba-Badiale</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2000</year>). <article-title>A Molecular Link between the Sudden Infant Death Syndrome and the Long-QT Syndrome</article-title>. <source>N. Engl. J.&#x20;Med.</source> <volume>343</volume> (<issue>4</issue>), <fpage>262</fpage>&#x2013;<lpage>267</lpage>. <pub-id pub-id-type="doi">10.1056/NEJM200007273430405</pub-id> </citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Selga</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Campuzano</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Pinsach-Abuin</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>P&#xe9;rez-Serra</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mademont-Soler</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Riur&#xf3;</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Comprehensive Genetic Characterization of a Spanish Brugada Syndrome Cohort</article-title>. <source>PLoS One</source> <volume>10</volume> (<issue>7</issue>), <fpage>e0132888</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0132888</pub-id> </citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shin</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Jang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>H. Y.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.&#x20;E.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>). <article-title>Genetic Analysis of the Cardiac Sodium Channel Gene SCN5A in Koreans with Brugada Syndrome</article-title>. <source>J.&#x20;Hum. Genet.</source> <volume>49</volume> (<issue>10</issue>), <fpage>573</fpage>&#x2013;<lpage>578</lpage>. <pub-id pub-id-type="doi">10.1007/s10038-004-0182-z</pub-id> </citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skinner</surname>
<given-names>J.&#x20;R.</given-names>
</name>
<name>
<surname>Winbo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Abrams</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Vohra</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wilde</surname>
<given-names>A. A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Channelopathies that Lead to Sudden Cardiac Death: Clinical and Genetic Aspects</article-title>. <source>Heart Lung Circ.</source> <volume>28</volume> (<issue>1</issue>), <fpage>22</fpage>&#x2013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/j.hlc.2018.09.007</pub-id> </citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Goldin</surname>
<given-names>A. L.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Interaction between the Sodium Channel Inactivation Linker and Domain III S4-S5</article-title>. <source>Biophys. J.</source> <volume>73</volume> (<issue>4</issue>), <fpage>1885</fpage>&#x2013;<lpage>1895</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-3495(97)78219-5</pub-id> </citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smits</surname>
<given-names>J.&#x20;P.</given-names>
</name>
<name>
<surname>Koopmann</surname>
<given-names>T. T.</given-names>
</name>
<name>
<surname>Wilders</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Veldkamp</surname>
<given-names>M. W.</given-names>
</name>
<name>
<surname>Opthof</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Bhuiyan</surname>
<given-names>Z. A.</given-names>
</name>
<etal/>
</person-group> (<year>2005a</year>). <article-title>A Mutation in the Human Cardiac Sodium Channel (E161K) Contributes to Sick Sinus Syndrome, Conduction Disease and Brugada Syndrome in Two Families</article-title>. <source>J.&#x20;Mol. Cel Cardiol</source>. <volume>38</volume> (<issue>6</issue>), <fpage>969</fpage>&#x2013;<lpage>981</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2005.02.024</pub-id> </citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smits</surname>
<given-names>J.&#x20;P.</given-names>
</name>
<name>
<surname>Veldkamp</surname>
<given-names>M. W.</given-names>
</name>
<name>
<surname>Bezzina</surname>
<given-names>C. R.</given-names>
</name>
<name>
<surname>Bhuiyan</surname>
<given-names>Z. A.</given-names>
</name>
<name>
<surname>Wedekind</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Schulze-Bahr</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2005b</year>). <article-title>Substitution of a Conserved Alanine in the Domain IIIS4-S5 Linker of the Cardiac Sodium Channel Causes Long QT Syndrome</article-title>. <source>Cardiovasc. Res.</source> <volume>67</volume> (<issue>3</issue>), <fpage>459</fpage>&#x2013;<lpage>466</lpage>. <pub-id pub-id-type="doi">10.1016/j.cardiores.2005.01.017</pub-id> </citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Son</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>B. H.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>B. W.</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>S. H.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Retrospective Genetic Analysis of 200 Cases of Sudden Infant Death Syndrome and its Relationship with Long QT Syndrome in Korea</article-title>. <source>J.&#x20;Korean Med. Sci.</source> <volume>33</volume> (<issue>32</issue>), <fpage>e200</fpage>. <pub-id pub-id-type="doi">10.3346/jkms.2018.33.e200</pub-id> </citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>R. B.</given-names>
</name>
<name>
<surname>Gando</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Bu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cecchin</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Coetzee</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>A Homozygous SCN5A Mutation Associated with Atrial Standstill and Sudden Death</article-title>. <source>Pacing Clin. Electrophysiol.</source> <pub-id pub-id-type="doi">10.1111/pace.13386</pub-id> </citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tarnovskaya</surname>
<given-names>S. I.</given-names>
</name>
<name>
<surname>Korkosh</surname>
<given-names>V. S.</given-names>
</name>
<name>
<surname>Zhorov</surname>
<given-names>B. S.</given-names>
</name>
<name>
<surname>Frishman</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Predicting Novel Disease Mutations in the Cardiac Sodium Channel</article-title>. <source>Biochem. Biophys. Res. Commun.</source> <volume>521</volume> (<issue>3</issue>), <fpage>603</fpage>&#x2013;<lpage>611</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2019.10.142</pub-id> </citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thongnak</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Limprasert</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Tangviriyapaiboon</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Silvilairat</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Puangpetch</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pasomsub</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>20162016</year>). <article-title>Exome Sequencing Identifies Compound Heterozygous Mutations in SCN5A Associated with Congenital Complete Heart Block in the Thai Population</article-title>. <source>Dis. Markers</source> <volume>2016</volume>, <fpage>3684965</fpage>. <pub-id pub-id-type="doi">10.1155/2016/3684965</pub-id> </citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tikhonov</surname>
<given-names>D. B.</given-names>
</name>
<name>
<surname>Bruhova</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Garden</surname>
<given-names>D. P.</given-names>
</name>
<name>
<surname>Zhorov</surname>
<given-names>B. S.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>State-dependent Inter-repeat Contacts of Exceptionally Conserved Asparagines in the Inner Helices of Sodium and Calcium Channels</article-title>. <source>Pflugers Arch.</source> <volume>467</volume> (<issue>2</issue>), <fpage>253</fpage>&#x2013;<lpage>266</lpage>. <pub-id pub-id-type="doi">10.1007/s00424-014-1508-0</pub-id> </citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tikhonov</surname>
<given-names>D. B.</given-names>
</name>
<name>
<surname>Zhorov</surname>
<given-names>B. S.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Architecture and Pore Block of Eukaryotic Voltage-Gated Sodium Channels in View of NavAb Bacterial Sodium Channel Structure</article-title>. <source>Mol. Pharmacol.</source> <volume>82</volume> (<issue>1</issue>), <fpage>97</fpage>&#x2013;<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1124/mol.112.078212</pub-id> </citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tikhonov</surname>
<given-names>D. B.</given-names>
</name>
<name>
<surname>Zhorov</surname>
<given-names>B. S.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Mechanism of Sodium Channel Block by Local Anesthetics, Antiarrhythmics, and Anticonvulsants</article-title>. <source>J.&#x20;Gen. Physiol.</source> <volume>149</volume> (<issue>4</issue>), <fpage>465</fpage>&#x2013;<lpage>481</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.201611668</pub-id> </citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsushima</surname>
<given-names>R. G.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Backx</surname>
<given-names>P. H.</given-names>
</name>
</person-group> (<year>1997a</year>). <article-title>Altered Ionic Selectivity of the Sodium Channel Revealed by Cysteine Mutations within the Pore</article-title>. <source>J.&#x20;Gen. Physiol.</source> <volume>109</volume> (<issue>4</issue>), <fpage>463</fpage>&#x2013;<lpage>475</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.109.4.463</pub-id> </citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsushima</surname>
<given-names>R. G.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Backx</surname>
<given-names>P. H.</given-names>
</name>
</person-group> (<year>1997b</year>). <article-title>P-loop Flexibility in Na&#x2b; Channel Pores Revealed by Single- and Double-Cysteine Replacements</article-title>. <source>J.&#x20;Gen. Physiol.</source> <volume>110</volume> (<issue>1</issue>), <fpage>59</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.110.1.59</pub-id> </citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valdivia</surname>
<given-names>C. R.</given-names>
</name>
<name>
<surname>Ackerman</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Tester</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Wada</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>McCormack</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2002</year>). <article-title>A Novel SCN5A Arrhythmia Mutation, M1766L, with Expression Defect Rescued by Mexiletine</article-title>. <source>Cardiovasc. Res.</source> <volume>55</volume> (<issue>2</issue>), <fpage>279</fpage>&#x2013;<lpage>289</lpage>. <pub-id pub-id-type="doi">10.1016/s0008-6363(02)00445-5</pub-id> </citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Veerman</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Wilde</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Lodder</surname>
<given-names>E. M.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>The Cardiac Sodium Channel Gene SCN5A and its Gene Product NaV1.5: Role in Physiology and Pathophysiology</article-title>. <source>Gene</source> <volume>573</volume> (<issue>2</issue>), <fpage>177</fpage>&#x2013;<lpage>187</lpage>. <pub-id pub-id-type="doi">10.1016/j.gene.2015.08.062</pub-id> </citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walsh</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>N. S.</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Ware</surname>
<given-names>J.&#x20;S.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Paralogue Annotation Identifies Novel Pathogenic Variants in Patients with Brugada Syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia</article-title>. <source>J.&#x20;Med. Genet.</source> <volume>51</volume> (<issue>1</issue>), <fpage>35</fpage>&#x2013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1136/jmedgenet-2013-101917</pub-id> </citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weiner</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Kollman</surname>
<given-names>P. A.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>D. T.</given-names>
</name>
<name>
<surname>Case</surname>
<given-names>D. A.</given-names>
</name>
</person-group> (<year>1986</year>). <article-title>An All Atom Force Field for Simulations of Proteins and Nucleic Acids</article-title>. <source>J.&#x20;Comput. Chem.</source> <volume>7</volume> (<issue>2</issue>), <fpage>230</fpage>&#x2013;<lpage>252</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.540070216</pub-id> </citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wisedchaisri</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Tonggu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>McCord</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Gamal El-Din</surname>
<given-names>T. M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Resting-State Structure and Gating Mechanism of a Voltage-Gated Sodium Channel</article-title>. <source>Cell</source> <volume>178</volume> (<issue>4</issue>), <fpage>993</fpage>&#x2013;<lpage>e12</lpage>. <comment>e1012</comment>. <pub-id pub-id-type="doi">10.1016/j.cell.2019.06.031</pub-id> </citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zakliaz&#x27;minskaia</surname>
<given-names>E. V.</given-names>
</name>
<name>
<surname>Shestak</surname>
<given-names>A. G.</given-names>
</name>
<name>
<surname>Revishvili</surname>
<given-names>A. Sh.</given-names>
</name>
<name>
<surname>Pronicheva</surname>
<given-names>I. V.</given-names>
</name>
<name>
<surname>Podoliak</surname>
<given-names>D. G.</given-names>
</name>
<name>
<surname>Nechaenko</surname>
<given-names>M. A.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Clinic and Genetic Polymorphism of Brugada Syndrome in Russian Patients, Caused by Mutation in SCN5A Gene</article-title>. <source>Khirurgiia (Mosk)</source> (<issue>2</issue>), <fpage>49</fpage>&#x2013;<lpage>53</lpage>. </citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeng</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>p.D1690N Sodium Voltage-Gated Channel&#xa0;&#x3b1; Subunit&#xa0;5 Mutation Reduced Sodium Current Density and Is Associated with Brugada Syndrome</article-title>. <source>Mol. Med. Rep.</source> <volume>13</volume> (<issue>6</issue>), <fpage>5216</fpage>&#x2013;<lpage>5222</lpage>. <pub-id pub-id-type="doi">10.3892/mmr.2016.5162</pub-id> </citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhorov</surname>
<given-names>B. S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Possible Mechanism of Ion Selectivity in Eukaryotic Voltage-Gated Sodium Channels</article-title>. <source>J.&#x20;Phys. Chem. B</source> <volume>125</volume> (<issue>8</issue>), <fpage>2074</fpage>&#x2013;<lpage>2088</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jpcb.0c11181</pub-id> </citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhorov</surname>
<given-names>B. S.</given-names>
</name>
</person-group> (<year>1981</year>). <article-title>A Vector Method for Calculating the Derivatives of the Energy of the Atom-Atom Interactions of Complex Molecules with Respect to Generalized Coordinates</article-title>. <source>J.&#x20;Struct. Chem.</source> <volume>22</volume>, <fpage>4</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1007/bf00745970</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>